WO2018186324A1 - Latent image aqueous ink composition, usage method and printed object thereof, printed object of solid preparation, and method for printing solid preparation - Google Patents

Latent image aqueous ink composition, usage method and printed object thereof, printed object of solid preparation, and method for printing solid preparation Download PDF

Info

Publication number
WO2018186324A1
WO2018186324A1 PCT/JP2018/014057 JP2018014057W WO2018186324A1 WO 2018186324 A1 WO2018186324 A1 WO 2018186324A1 JP 2018014057 W JP2018014057 W JP 2018014057W WO 2018186324 A1 WO2018186324 A1 WO 2018186324A1
Authority
WO
WIPO (PCT)
Prior art keywords
latent image
visible
red
ink layer
printing
Prior art date
Application number
PCT/JP2018/014057
Other languages
French (fr)
Japanese (ja)
Inventor
悠人 榎本
Original Assignee
株式会社Screenホールディングス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2017112878A external-priority patent/JP6943636B2/en
Priority claimed from JP2018036818A external-priority patent/JP7204084B2/en
Application filed by 株式会社Screenホールディングス filed Critical 株式会社Screenホールディングス
Publication of WO2018186324A1 publication Critical patent/WO2018186324A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B41PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41JTYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
    • B41J2/00Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed
    • B41J2/005Typewriters or selective printing mechanisms characterised by the printing or marking process for which they are designed characterised by bringing liquid or particles selectively into contact with a printing material
    • B41J2/01Ink jet
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B41PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41MPRINTING, DUPLICATING, MARKING, OR COPYING PROCESSES; COLOUR PRINTING
    • B41M3/00Printing processes to produce particular kinds of printed work, e.g. patterns
    • B41M3/14Security printing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B41PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
    • B41MPRINTING, DUPLICATING, MARKING, OR COPYING PROCESSES; COLOUR PRINTING
    • B41M5/00Duplicating or marking methods; Sheet materials for use therein
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00Inks
    • C09D11/30Inkjet printing inks
    • C09D11/32Inkjet printing inks characterised by colouring agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D11/00Inks
    • C09D11/50Sympathetic, colour changing or similar inks
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials

Definitions

  • the present invention relates to an aqueous ink composition for a latent image, a method of use, and a printed material. More specifically, for example, on a recording medium such as a pharmaceutical, an image that is a latent image in the visible light region and is visualized after ultraviolet irradiation. It is related with the aqueous ink composition for latent images which can print, and a usage method and printed matter.
  • the present invention also relates to a printed matter of a solid preparation and a printing method of the solid preparation, and more specifically, to a solid preparation such as a pharmaceutical or food, a latent image that can be visualized by ultraviolet irradiation, and under visible light irradiation.
  • the present invention relates to a printed matter of a solid preparation on which a visible image that can be visually recognized is printed, and a printing method of the solid preparation.
  • Patent Document 1 uses a squid ink pigment composed of particles having a particle size of 10 nm or more and 1 ⁇ m or less as a food pigment. It is disclosed.
  • Patent Document 2 discloses that the edible inkjet ink composition uses a synthetic dye aluminum lake as a food dye.
  • Patent Document 3 discloses that a water-soluble ink composed only of a dye-based food coloring is used to print an image on the surface of a solid preparation.
  • the present invention has been made in view of the above-mentioned problems, and a first object thereof is a latent image in which visibility is suppressed under a visible light region, and the latent image is visualized after ultraviolet irradiation. It is an object to provide a latent aqueous ink composition for latent images, a method of use, and a printed matter.
  • the second object of the present invention is a latent image that is difficult to visually recognize under irradiation with visible light and can be visualized by irradiation with ultraviolet light, and a visible image that is visible under irradiation with visible light. It is providing the printed matter of a solid formulation which has these, and the printing method of a solid formulation.
  • the aqueous ink composition for a latent image according to the present invention is an aqueous ink composition for a latent image for printing a latent image, having light transmittance in a visible light region, in order to solve the above-described problems.
  • At least a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and the fluorescent agent is riboflavin, riboflavin butyrate, sodium riboflavin phosphate, cinnamic acid derivative, L-tryptophan , Tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red 3, red 104, red 105, red 106, at least one selected from the group consisting of fumarate, chlorophyll and rhodamine
  • the content of the fluorescent agent is 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images. Characterized in that it is in the range of.
  • the aqueous ink composition for latent images having the above structure (hereinafter sometimes referred to as “aqueous ink composition”) has light transmittance in the visible light region, the aqueous ink composition is used.
  • the aqueous ink composition is used.
  • the water-based ink composition having the above-described structure contains a fluorescent agent that emits fluorescence when irradiated with ultraviolet rays in a wavelength region of 100 nm to 400 nm, a printed image composed of a latent image is irradiated with light containing ultraviolet rays in the wavelength region. Can visualize the printed image under a visible light region.
  • the content of the fluorescent agent is 0.001% by mass to 10% by mass or less with respect to the total mass of the aqueous ink composition.
  • the aqueous ink composition for a latent image is used for printing a latent image by an inkjet method on a solid preparation, and the fluorescent agent is edible.
  • the water-based ink composition of the present invention makes it possible to print a latent image that can be visualized by irradiation with ultraviolet rays in the wavelength range. Therefore, when a solid preparation is used as a recording medium and product information is printed as a latent image on the recording medium, it becomes difficult to visually recognize the product information etc. under the visible light region, thus suppressing the production of counterfeit products. Can do. When it is desired to confirm an image such as product information printed as a latent image or to confirm the authenticity of a product, this can be visualized by irradiating the printed image including the latent image with ultraviolet rays. .
  • the method for using the latent image aqueous ink according to the present invention uses a latent image aqueous ink containing a latent image aqueous ink composition to form a latent image on a recording medium.
  • the latent image ink layer generates fluorescence in the visible light region and visualizes the latent image
  • the latent image water-based ink composition has a wavelength range of 100 nm to 400 nm.
  • a fluorescent agent that emits fluorescence in the region is riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, Quinine sulfate, Red No. 3, Red No. 104, Red No. 105, Red No.
  • At least one selected from the group consisting of fumarate, chlorophyll and rhodamine, and the content of the fluorescent agent is an aqueous ink for latent images
  • a composition having a composition in the range of 0.001% by mass to 10% by mass with respect to the total mass of the composition is used.
  • the latent image water-based ink (hereinafter sometimes referred to as “water-based ink”) includes the water-based ink composition having light transmittance in the visible light region.
  • water-based ink includes the water-based ink composition having light transmittance in the visible light region.
  • the aqueous ink composition contains a fluorescent agent that emits fluorescence when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm
  • the latent image ink layer contains light containing at least ultraviolet rays in the wavelength range. , The latent image can be visualized (visualized) in the visible light region.
  • a solid preparation can be used as the recording medium.
  • the method of use of the present invention includes a step of printing a latent image that can be visualized by irradiation with ultraviolet rays in the wavelength range. Therefore, when a solid preparation is used as a recording medium and product information is printed as a latent image on the recording medium, it becomes difficult to visually recognize the product information etc. under the visible light region, thus suppressing the production of counterfeit products. Can do. If you want to check the product information image printed as a latent image, or if you want to check the authenticity of the product, you can visualize this by irradiating the printed image containing the latent image with ultraviolet rays. it can.
  • the printed material according to the present invention is a printed material in which a latent image is provided on at least a part of the surface of the recording medium, and the latent image is light transmissive to visible light.
  • a latent image ink layer that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and the latent image ink layer is riboflavin, riboflavin butyrate, sodium riboflavin phosphate Cinnamic acid derivatives, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red 3, red 104, red 105, red 106, fumarate, chlorophyll and rhodamine It includes at least one fluorescent agent selected from the group consisting of:
  • the latent image ink layer provided on the recording medium has light transmittance under the visible light region and includes a latent image. Can be difficult. Since the latent image ink layer contains a fluorescent agent capable of emitting fluorescence when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm, the printed matter having the above structure is irradiated with light containing the ultraviolet rays. By generating fluorescence in the latent image ink layer, the latent image ink layer including the latent image can be visualized.
  • the recording medium can be a solid preparation.
  • product information when product information is printed with a latent image ink layer containing a latent image, it is difficult to visually recognize under the visible light region, so that it is possible to make it difficult to manufacture a counterfeit product on which the product information is printed.
  • the product information formed by the latent image ink layer can be easily visualized by irradiating the latent image ink layer with ultraviolet rays, so the printed product information can be confirmed and dispensing errors can occur. Can be suppressed, and the authenticity of the product can be confirmed.
  • a printed matter of a solid preparation is a printed matter of a solid preparation in which a latent image and a visible image are provided on at least a part of the surface.
  • Consists of a latent image ink layer that is transparent to visible light and emits fluorescence in the visible light region when irradiated with ultraviolet light in the wavelength range of 100 nm to 400 nm.
  • the visible image is visible under visible light irradiation. It consists of a possible visible ink layer.
  • a latent image composed of the latent image ink layer and a visible image composed of the visible ink layer are provided on at least a part of the surface of the solid preparation. Since the latent image ink layer has a light-transmitting property with respect to visible light, it is difficult to visually recognize the latent image made of the latent image ink layer under irradiation of visible light. Further, since the latent image ink layer emits fluorescence in the visible light region when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm, the latent image formed of the latent image ink layer is visualized (visualized) under the irradiation of the ultraviolet rays, It can be visually recognized well.
  • the visible ink layer can be viewed under irradiation with visible light, a visible image made of the visible ink layer can be viewed well under irradiation with visible light. Therefore, when the solid preparation is a printed matter having the above-described configuration, it becomes possible to record information on the surface of the solid preparation as a latent image or a visible image according to the content of the information, and the degree of freedom of the information recording method is improved. be able to.
  • the latent image ink layer is composed of riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, It is preferable to include at least one fluorescent agent selected from the group consisting of Red No. 3, Red No. 104, Red No. 105, Red No. 106, fumarate, chlorophyll and rhodamine.
  • the latent image ink layer is formed of a dry film of a latent image aqueous ink
  • the latent image aqueous ink includes the latent image aqueous ink composition containing the fluorescent agent.
  • the content of the fluorescent agent is preferably in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous coating composition.
  • the latent image ink layer is made of a dry film of the water-based ink printed using the latent image water-based ink (hereinafter sometimes referred to as “water-based ink”). Can do.
  • the fluorescent agent is added in an amount of 0.001 mass relative to the total mass of the aqueous ink composition. Since it is contained in the range of 10% to 10% by weight, it is possible to print a latent image while maintaining light transmittance in the visible light region.
  • the solubility of the fluorescent agent in the aqueous ink composition is prevented from excessively decreasing, for example, when printing a latent image ink layer by an inkjet method, the ejection stability from the inkjet nozzle is improved. It can maintain and can suppress that flying property falls.
  • the visible ink layer and the latent image ink layer may be provided in different regions on the surface, or may be sequentially stacked on the surface at least partially overlapping each other.
  • the latent image ink layer and the visible ink layer are formed in different regions on the surface of the solid preparation, the latent image visualized by the irradiation of the ultraviolet ray and the visible image are visually recognized. Can be prevented.
  • the latent image ink layer and the visible ink layer are laminated in a state where at least part of them overlap, more information can be obtained even when the area of the printable region on the solid preparation is small. Can be recorded.
  • the latent image ink layer is laminated on the visible ink layer.
  • the entire area of the latent image ink layer can be irradiated with ultraviolet rays at the time of visualization by irradiation with the ultraviolet rays, and the latent image can be visualized in a good state.
  • the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
  • the solid preparation printing method according to the present invention is a solid preparation printing method for printing a latent image and a visible image on at least a part of the surface of the solid preparation in order to solve the above-mentioned problems,
  • a visible ink layer that is visible under irradiation with visible light is printed to form the visible image, a visible image printing region, a region different from the visible image printing region,
  • An area that is different from the area to be printed or an area that at least partially overlaps the visible image printing area has optical transparency to visible light and is visible by irradiation with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
  • the visible ink layer that is visible under visible light irradiation is printed on the surface of the solid preparation, thereby forming a visible image.
  • the latent image ink has a light-transmitting property with respect to visible light on the surface of the solid preparation and emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm. Form a layer. Thereby, it is difficult to visually recognize under irradiation of visible light, and a latent image that can be visualized by emitting fluorescence can be formed under irradiation of ultraviolet rays in the wavelength range.
  • the latent image ink layer in the latent image printing step is performed in an area different from the print area of the visible image or an area different from the print scheduled area of the visible image
  • the latent image ink layer is exposed by the irradiation of the ultraviolet rays. It is possible to prevent the visualized latent image and the visible image from being visually recognized.
  • the latent image ink layer is printed in an area at least partially overlapping the print area of the visible image, more information is obtained when the area of the printable area on the solid preparation is small. Can be recorded on the formulation surface.
  • the latent image ink layer is printed in an area at least partially overlapping the visible image print area, the latent image ink layer is printed so as to be partially laminated on the visible ink layer.
  • the entire area of the latent image ink layer can be irradiated with ultraviolet rays at the time of visualization by irradiation with the ultraviolet rays, and the latent image can be visualized in a good state.
  • the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
  • the latent image printing step is a step of printing the latent image ink layer by an inkjet method using a latent image aqueous ink containing a latent image aqueous ink composition
  • the aqueous ink composition for latent images contains a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and has light transmittance in the visible light region. preferable.
  • a latent image aqueous ink for printing a latent image ink layer by using a latent image water-based ink composition having light transmittance in the visible light region, the latent image ink layer can be visually recognized under irradiation with visible light. A difficult latent image ink layer can be formed. Also, a latent image ink layer that can be visualized by generating fluorescence in the visible light region upon irradiation with the ultraviolet rays is formed by using the aqueous ink composition for latent images containing the fluorescent agent. can do.
  • the fluorescent agent includes riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, It is preferable to use at least one selected from the group consisting of Red No. 3, Red No. 104, Red No. 105, Red No. 106, fumarate, chlorophyll and rhodamine.
  • the content of the fluorescent agent is preferably 0.001% by mass to 10% by mass with respect to the total mass of the latent image water-based ink composition.
  • a water-based ink containing a fluorescent agent in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images, light transmittance in the visible light region is maintained. It becomes possible to print the latent image.
  • the solubility of the fluorescent agent in the latent ink composition for the latent image is prevented from excessively decreasing, and the ejection stability from the ink jet nozzle is well maintained, and the flying property is suppressed from decreasing. Can do.
  • the aqueous ink composition for latent images of the present invention contains a fluorescent agent that has optical transparency in the visible light region and emits fluorescence when irradiated with ultraviolet rays having a wavelength region of 100 nm to 400 nm. Therefore, for example, when the aqueous ink composition for latent images of the present invention is used for printing in an ink jet system, it is difficult to visually recognize under the visible light region, and emits fluorescence after being irradiated with the ultraviolet rays. Thus, a latent image that can be visualized can be printed as a print image.
  • aqueous ink composition for latent images of the present invention when used for printing product information on a solid preparation, it becomes possible to prevent the production of counterfeit products.
  • print images can be easily visualized by irradiating light containing ultraviolet rays in the wavelength range of at least 100 nm to 400 nm. There is an effect that can be done.
  • a visible image composed of a visible ink layer that is visible under irradiation with visible light, light transmittance with respect to visible light, and a wavelength range of 100 nm to 400 nm.
  • a configuration having a latent image composed of a latent image ink layer that emits fluorescence in the visible light region when irradiated with ultraviolet rays in a range is employed.
  • product information that can be visually recognized is printed as a visible image, and product information necessary for confirmation of preparation or product authenticity is printed as a latent image. It is possible to provide a printed matter of a solid preparation with an improved degree of freedom.
  • the method for printing a solid preparation of the present invention it is possible to record information on the surface of the solid preparation, depending on the content of the information, etc., while properly using the latent image or visible image. It is possible to provide a method for printing a solid preparation capable of improving the degree of freedom.
  • the latent image aqueous ink composition according to Embodiment 1 will be described below.
  • the aqueous ink composition for latent images of the first embodiment is a composition containing at least a fluorescent agent and using water as a main solvent.
  • the latent image aqueous ink composition of the first embodiment has edible properties by using a material that complies with the standards of pharmaceutical additives, Japanese Pharmacopoeia or Food Additives specified by the Pharmaceutical Affairs Law. And can be suitably used for recording an image or the like by an inkjet method.
  • “edible” means a substance that is approved for oral administration as a pharmaceutical product or pharmaceutical additive and / or a food product or food additive.
  • the “inkjet method” means that a latent image aqueous ink containing a latent image aqueous ink composition is ejected as droplets from a fine inkjet head, and the droplets are fixed on a recording medium. Means a method of forming an image. Details of the recording medium will be described later.
  • the latent ink composition for latent images preferably has a light transmittance in the visible light region (400 nm to 760 nm).
  • the latent image ink layer when the latent image ink layer is formed using the latent image aqueous ink containing the latent image aqueous ink composition, the latent image ink layer can be provided with a light-transmitting property with respect to visible light.
  • the light transmittance of the latent ink composition for a latent image may be colored as well as colorless.
  • “light-transmitting” means a property of transmitting at least a part of incident visible light.
  • the fluorescent agent is a component that, when irradiated with ultraviolet rays (excitation light) having a wavelength range of 100 nm to 400 nm, absorbs the ultraviolet rays and converts the wavelength into the visible light range (380 nm to 760 nm) to emit fluorescence.
  • ultraviolet rays excitation light
  • vitamin B group such as riboflavin, riboflavin butyrate and sodium riboflavin phosphate; cinnamic acid derivatives such as methyl cinnamate and ethyl cinnamate; amino acids such as L-tryptophan, tyrosine and phenylalanine; quinine Quinine hydrochlorides such as quinine hydrochloride dihydrate and quinine sulfate; colored fluorescent dyes such as red 3, red 104, red 105 and red 106; fumarate such as disodium fumarate and monosodium fumarate Acid (alkali metal) salts; basic dyes such as chlorophyll and rhodamine, beeswax etc. .
  • These fluorescent agents can be used alone or in combination of two or more.
  • methyl cinnamate, ethyl cinnamate, L-tryptophan, tyrosine, phenylalanine, and fumaric acid (alkali metal) salts are colorless and transparent, and other fluorescent agents are colored and transparent.
  • riboflavin phosphate sodium red No. 3, red No. 104, red 106 from the viewpoint of improving visibility when fluorescence is generated and visualized. No. is preferred. From the standpoint of ensuring good ejection performance from the inkjet head, riboflavin, riboflavin phosphate sodium ester, L-tryptophan, red No. 104, and red No. 106 are preferable.
  • fluorescence includes visible light emitted from the fluorescent agent during the ultraviolet irradiation, and visible light having a short decay time among the afterglow emitted from the fluorescent agent even after the ultraviolet irradiation is completed. Meaning.
  • the decay time means the time required for the transition from the start of light emission of the fluorescent agent to the return to the ground state (fluorescence disappears).
  • the fluorescent agent is preferably edible.
  • the fluorescent agent has a relatively long decay time and has a luminous property. Thereby, even after the end of ultraviolet irradiation, the visibility of the visualized printed image can be improved by confirming the afterglow emitted by the fluorescent agent.
  • the content of the fluorescent agent is preferably 0.001% by mass to 10% by mass with respect to the total mass of the latent ink aqueous ink composition. More preferably, it is within the range of 2% by mass to 2% by mass. Further, when the fluorescent agent is colored and transparent, it is preferably 0.001% by mass to 10% by mass, and preferably 0.01% by mass to 1% by mass with respect to the total mass of the latent image aqueous ink composition. More preferably within the range. By setting the content of the fluorescent agent to 10% by mass or less, it is possible to make it difficult to visually recognize an image printed as a latent image.
  • the content of the fluorescent agent is 0.001% by mass or more, it is possible to prevent the latent image ink layer from becoming difficult to visually recognize even after the ultraviolet irradiation.
  • the content of the fluorescent agent is within the numerical range, considering the visibility of the printed image when the latent image ink layer is formed, the visibility of the latent image ink layer when the fluorescence is generated, and the like. It is preferable to set for each type of fluorescent agent mentioned above.
  • a dye that does not emit fluorescence may be blended.
  • dyes include azo dyes and triphenylmethane dyes.
  • the azo dye is not particularly limited, and examples thereof include Red No. 102, Red No. 40, Yellow No. 4, Yellow No. 5, and the like.
  • the triphenylmethane dye is not particularly limited, and examples thereof include blue No. 1 and green No. 3.
  • edible natural pigments such as cochineal pigment, copper chlorophyllin sodium, cacao pigment and caramel pigment together.
  • additives may be blended.
  • other additives include surface tension adjusting agents, wetting agents, water-soluble resins, organic amines, surfactants, pH adjusting agents, chelating agents, preservatives, viscosity adjusting agents, and antifoaming agents.
  • these other additives are pharmaceutical additives specified by the Pharmaceutical Affairs Law, Japan Pharmacy It is preferable that it complies with the standard of the method or food additive official standard.
  • the content of these additives is not particularly limited except for the surface tension adjusting agent and the wetting agent, and can be appropriately set as necessary (for the contents of the surface tension adjusting agent and the wetting agent, respectively. (It will be described later.)
  • the surface tension adjusting agent is not particularly limited, and specific examples include glycerin fatty acid esters and polyglycerin fatty acid esters.
  • examples of the glycerin fatty acid ester include caprylic acid decaglyceryl, lauric acid hexaglycerin ester, oleic acid hexaglycerin ester, condensed linolenic acid tetraglycerin ester, fatty acid ester palm palm, lauric acid decaglyceryl having an HLB of 15 or less, and HLB.
  • Examples include decaglyceryl oleate of less than 13. You may use these individually by 1 type or in mixture of 2 or more types.
  • all of the exemplified surface tension adjusting agents conform to standards such as the Pharmaceutical Affairs Law, they can be applied to printing on solid preparations.
  • caprylic acid decaglyceryl As the caprylic acid decaglyceryl, it is possible to use a commercially available product.
  • a commercially available product examples include Ryoto (registered trademark) polyglycerate CE19D (trade name, manufactured by Mitsubishi Chemical Foods Co., Ltd., HLB). Value 15), SY glister MCA750 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 16), and the like.
  • the HLB value is an HLB value according to the Griffin method and means a value obtained by the following equation.
  • HLB value 20 ⁇ (sum of formula weight of hydrophilic group / molecular weight)
  • the HLB value is a value in the range of 0 to 20. The larger the HLB value, the stronger the hydrophilicity, and the smaller the HLB value, the stronger the hydrophobicity.
  • the decaglyceryl laurate those having an HLB of 15 or less can be used.
  • the decaglyceryl laurate has an HLB of more than 15, the ejection stability is lowered, for example, the occurrence of fading due to clogging of the nozzles of the inkjet head.
  • the lower limit of HLB is preferably 10 or more from the viewpoint of solubility in an aqueous solvent.
  • a commercially available product can be used as decaglyceryl laurate having an HLB of 15 or less.
  • NIKKOL registered trademark
  • DECAGLYN 1-L trade name, Nikko Chemicals ( HLB value 14.5)
  • SY Glister ML-750 trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 14.8, and the like.
  • the decaglyceryl oleate those having an HLB of less than 13 can be used.
  • the HLB is 13 or more, the ejection stability is deteriorated, such as blurring due to clogging of the nozzles of the inkjet head.
  • the minimum of HLB is 10 or more from a viewpoint of the solubility with respect to a water solvent.
  • a commercially available product can be used as decaglyceryl oleate having an HLB of less than 13 as decaglyceryl oleate having an HLB of less than 13, a commercially available product can be used.
  • Examples of such a commercially available product include NIKKOL (registered trademark) DECAGLYN 1-OV (trade name, Nikko Chemicals ( Co., Ltd., HLB value 12), SY Glister MO-7S (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 12.9), and the like.
  • lauric acid hexaglycerin ester a commercially available product can be used, and as such a commercially available product, for example, NIKKOL (registered trademark) HEXAGLYN 1-L (trade name, manufactured by Nikko Chemicals Co., Ltd., HLB) Value 14.5), SY Glister ML-500 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 13.5), and the like.
  • NIKKOL registered trademark
  • HEXAGLYN 1-L trade name, manufactured by Nikko Chemicals Co., Ltd., HLB Value 14.5
  • SY Glister ML-500 trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 13.5
  • oleic acid hexaglycerin ester examples include SY Glyster MO-5S (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 11. 6) and the like.
  • fatty acid ester palm palm a commercially available product can be used, and examples of such a commercially available product include Tirabazole W-01 (trade name, manufactured by Taiyo Kagaku Co., Ltd.).
  • the content of the surface tension adjusting agent is preferably within a range of 0.1% by mass to 5% by mass with respect to the total mass of the aqueous ink composition for latent images, and within a range of 1% by mass to 2% by mass. It is more preferable that When the content of the surface tension adjusting agent is 0.1% by mass or more, when printing is performed by an inkjet method, ejection failure due to meniscus formation failure or the like at the nozzle in the inkjet head is prevented, and the nozzle is clogged. Can be prevented. As a result, the discharge stability can be improved. On the other hand, when the content of the surface tension adjusting agent is 5% by mass or less, it is possible to prevent an adverse effect on discharge due to insoluble matter or poor emulsification of the surface tension adjusting agent.
  • the wetting agent is not particularly limited, and specific examples include polyethylene glycol, propylene glycol, glycerin and the like. In addition, since these wetting agents meet standards such as the Pharmaceutical Affairs Law, they can also be applied to printing on solid preparations.
  • the amount of the wetting agent added is preferably 1% by mass to 50% by mass, and more preferably 10% by mass to 40% by mass with respect to the total mass of the latent image aqueous ink composition.
  • the latent image aqueous ink composition of the present embodiment contains water (water as a main solvent).
  • water it is preferable to use water from which ionic impurities such as ion-exchanged water, ultrafiltered water, reverse osmosis water, distilled water, or ultrapure water have been removed.
  • ionic impurities such as ion-exchanged water, ultrafiltered water, reverse osmosis water, distilled water, or ultrapure water have been removed.
  • water sterilized by ultraviolet irradiation or addition of hydrogen peroxide is preferable because generation of mold and bacteria can be prevented over a long period of time.
  • it does not specifically limit as content of water, It can set suitably as needed.
  • the viscosity of the latent ink composition for a latent image is preferably 2 mPa ⁇ s to 6 mPa ⁇ s, more preferably 3 mPa ⁇ s to 5 mPa ⁇ s at the time of ink jet nozzle ejection, in consideration of ejection stability from the ink jet nozzle.
  • the viscosity of the latent image water-based ink composition is obtained, for example, by measuring the viscosity at a measurement temperature of 25 ° C. using a viscometer (trade name: VISCOMATE MODEL VM-10A, manufactured by Seconic Corporation). It is done.
  • the aqueous ink composition for latent images of the present embodiment can be produced by mixing the above-described components by an appropriate method.
  • the mixing method and the order of addition are not particularly limited. After mixing, the mixture is sufficiently stirred, and if necessary, filtration is performed to remove coarse particles and foreign matters that cause clogging. Thereby, the aqueous ink composition for latent images according to the present embodiment can be obtained.
  • each material is not particularly limited, and for example, the materials can be sequentially added to a container equipped with a stirring device such as a disper, a mechanical stirrer, or a magnetic stirrer to perform stirring and mixing.
  • a stirring device such as a disper, a mechanical stirrer, or a magnetic stirrer to perform stirring and mixing.
  • it does not specifically limit as a filtration method, For example, centrifugal filtration, filter filtration, etc. are employable.
  • the storage of the latent ink for a latent image is preferably performed using a light-shielding container capable of shielding at least ultraviolet rays (wavelength range of 100 nm to 400 nm). This suppresses photodegradation of the fluorescent agent in the aqueous ink composition for latent images, and can be stored for a long period of time.
  • the light-shielding container is not particularly limited, and a conventionally known container such as an aluminum container, a colored container, or a synthetic resin container containing an ultraviolet absorber can be used.
  • the latent image aqueous ink of the present embodiment includes at least the above-described latent image aqueous ink composition.
  • a latent ink for a latent image containing a pharmaceutical additive stipulated by the Pharmaceutical Affairs Law, a fluorescent agent that conforms to the standards of the Japanese Pharmacopoeia or the Food Additives Standard, etc.
  • the water-based ink is edible, it can be directly printed on the surface of a solid agent comprising tablets or capsules such as pharmaceuticals or supplements.
  • non-contact printing by an ink jet method is possible even for tablets with poor surface smoothness such as uncoated tablets and OD tablets.
  • the method for storing the latent image water-based ink is the same as that of the above-described latent image water-based ink composition.
  • the method of using the latent ink for latent image according to the first embodiment includes a printing process for printing a latent image ink layer including a latent image, and irradiating the latent image ink layer with ultraviolet rays to visualize (visualize) the latent image. At least a visualization step.
  • the printing process of the latent image ink layer is a process of printing and forming the latent image ink layer on the recording medium by an ink jet method. More specifically, the latent image aqueous ink containing the latent image aqueous ink composition is ejected as droplets from a fine nozzle, and the droplets are deposited on a recording medium.
  • the method of discharging the latent image water-based ink For example, a known method such as a continuous ejection type (charge control type, spray type, etc.), on-demand type (piezo type, thermal type, electrostatic suction type, etc.) Can be adopted.
  • Printing conditions such as ink droplet ejection amount and printing speed are not particularly limited, and can be set as necessary.
  • the printing process includes a drying process for drying ink droplets attached to the surface of the solid preparation. It does not specifically limit as a drying method, In addition to hot air drying, natural drying etc. can be performed. Also, the drying conditions such as drying time and drying temperature are not particularly limited, and can be appropriately set according to the ejection amount of ink droplets, the type of the latent image aqueous ink composition, and the like.
  • the latent image visualization step is a step that enables visualization of a printed image by irradiating the latent image ink layer printed in the printing step with light containing ultraviolet rays in a wavelength region of at least 100 nm to 400 nm. is there.
  • the fluorescent agent uniformly contained in the latent image ink layer absorbs the ultraviolet rays and emits (fluoresces) light in the visible light region (380 nm to 760 nm). Thereby, the entire latent image ink layer in which the fluorescent agent is present emits fluorescence and is visualized.
  • the latent image ink layer before ultraviolet irradiation when the latent image ink layer before ultraviolet irradiation is colorless and transparent in the visible light region, the latent image ink layer can be visualized by fluorescence.
  • fluorescent dyes red No. 3, red No. 104, red No. 105 or red No. 106
  • basic dyes chlororophyll or rhodamine
  • the latent image ink layer before UV irradiation is colored in the visible light region.
  • the visibility is further improved by the fluorescence of the latent image ink layer.
  • Irradiation light used for visualization of the latent image is not particularly limited as long as it includes at least ultraviolet rays having a wavelength range of 100 nm to 400 nm. Therefore, in the visualization step, for example, it is possible to visualize the latent image using ultraviolet rays in the wavelength range in the presence of light in the visible range in the room.
  • most of the fluorescent agents used in the present embodiment have a maximum absorption wavelength in the range of 280 nm to 380 nm. For this reason, it is more preferable to include ultraviolet rays within a range of 280 nm to 380 nm in the light used for developing the latent image. Thereby, the ultraviolet absorption by the fluorescent agent is maximized, and the light intensity of the fluorescence emitted by the fluorescent agent can be further increased.
  • a filter with respect to the irradiation light.
  • a light emitting device that emits light including an ultraviolet region emits light in the visible light region in addition to the ultraviolet region. Therefore, if a filter or the like is used to block light other than the ultraviolet light in the wavelength range, the ultraviolet light is blocked by the filter as a result. As a result, the cumulative amount of ultraviolet light irradiated on the latent image ink layer. May also decrease. Thereby, the light intensity of the fluorescence emitted from the latent image ink layer may decrease.
  • the wavelength range of the ultraviolet rays contained in the irradiation light can be appropriately set according to the type of the fluorescent agent.
  • the integrated light amount (mJ / cm 2 ) of the irradiation light can be appropriately set according to the type of the fluorescent agent, the content in the latent image ink layer, the degree of photodegradability, and the like.
  • the latent image visualization step may include an observation step of observing the visualized printed image.
  • the observation method is not particularly limited, and imaging means such as a camera may be used in addition to visual observation.
  • the imaging means is not particularly limited, and can be appropriately selected according to the type of fluorescent agent or recording medium.
  • a latent image ink layer including a latent image is provided on a recording medium.
  • the latent image ink layer printed with the latent image water-based ink of the present embodiment is made of a dry film of the latent image water-based ink and has light transmittance in the visible light region.
  • the dry film is composed of at least a fluorescent agent contained in the latent image aqueous ink composition. The fluorescent agent is uniformly present in the latent image ink layer (dried film of the latent image aqueous ink).
  • the latent image ink layer includes a dry film of a latent image aqueous ink and forms at least a part of a printed image.
  • the printed image includes an image that can be visually recognized under the visible light region.
  • the type of the print image is not particularly limited, and examples thereof include a pattern, characters, patterns, and combinations thereof.
  • the print image is the product information represented by the characters. expressed.
  • the latent image ink layer has light transmittance in the visible light region.
  • “light transmissive” means a property of transmitting at least part of incident visible light. More specifically, the transmittance of visible light having a wavelength range of 400 nm to 800 nm is 50% or more with respect to the latent image ink layer having a thickness of 2 ⁇ m, preferably 50% or more, preferably The case is 70% or more, more preferably 90% or more.
  • the thickness of the latent image ink layer is not particularly limited, and is appropriately determined in consideration of the composition and printing speed of the latent image aqueous ink, the fixability of the droplets of the latent image aqueous ink, the drying speed, and the like. Can be set.
  • the recording medium is not particularly limited, and a conventionally known recording medium can be used. Specific examples include printing paper such as art paper, coated paper, and matte paper. Further, it can be applied to a solid preparation as a recording medium.
  • the term “solid preparation” includes food preparations and pharmaceutical preparations. Examples of solid preparation forms include OD tablets (orally disintegrating tablets), plain tablets, and FC (film coat) tablets. And tablets or capsules such as sugar-coated tablets.
  • the solid preparation may be used for pharmaceuticals or food. Examples of tablets for food use include health foods such as tablet confectionery and supplements.
  • the tablet is solid at room temperature, and for example, a tablet prepared by compressing and / or molding a tablet material containing an active ingredient into a certain shape is preferable.
  • the shape of the tablet is not particularly limited, and any shape can be adopted.
  • a solid preparation as a recording medium, it is possible to prevent deterioration of the printed image of various information printed to improve identification for the user such as product information. It is possible to provide a solid preparation that maintains visibility and prevents dispensing errors and accidental ingestion.
  • Embodiment 2 (Printed product of solid preparation)
  • the printed matter of the solid preparation according to the second embodiment will be described below.
  • the printed matter of the solid preparation of the second embodiment has a latent image and a visible image on at least a part of the surface.
  • the meaning of “solid preparation” is as described above.
  • the “latent image” means an image that is difficult to distinguish under an environment irradiated with visible light (wavelength range of greater than 400 nm and less than 760 nm) and is visualized under a specific condition.
  • the “visible image” means an image that can be identified in an environment irradiated with visible light (wavelength range: 400 nm to 760 nm).
  • the image printed as a latent image or a visible image can be printed by, for example, an inkjet method using an aqueous inkjet ink.
  • the latent image is composed of a latent image ink layer.
  • the latent image ink layer is preferably composed of a dry film of an aqueous ink for latent images applicable to inkjet printing (details are as described in Embodiment 1).
  • the dry film can be formed by directly printing on the surface of the solid preparation using the latent ink for latent images, for example, by an inkjet method or the like.
  • the latent image ink layer has optical transparency in the visible light region (greater than 400 nm and less than 760 nm). This makes it difficult to visually recognize the latent image ink layer under visible light irradiation.
  • “light transmissive” means a property of transmitting at least part of incident visible light. More specifically, the transmittance of visible light having a wavelength range of 400 nm to 760 nm is 50% or more with respect to the latent image ink layer having a thickness of 2 ⁇ m, preferably 50% or more, preferably The case is 70% or more, more preferably 90% or more.
  • the term “light transmissivity” means that the latent image ink layer is colored as well as colored.
  • the latent image ink layer contains a fluorescent agent, whereby the latent image ink layer emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
  • the thickness of the latent image ink layer is not particularly limited, and is appropriately determined in consideration of the composition and printing speed of the latent image aqueous ink, the fixability of the droplets of the latent image aqueous ink, the drying speed, and the like. Can be set.
  • the visible image is composed of a visible ink layer.
  • the visible ink layer is an ink layer that is visible under visible light irradiation.
  • the visible ink layer is preferably composed of a dry film of a water-based ink for visible images (details will be described later) that can be applied to printing by an inkjet method.
  • the dry film can be formed by printing directly on the surface of the solid preparation using the above-described aqueous ink for visible images, for example, by an ink jet method.
  • the latent image ink layer and the visible ink layer can be provided in different areas on the surface of the solid preparation.
  • a latent image ink layer can be provided on one side and a visible ink layer can be provided on the other side.
  • the latent image ink layer and the visible ink layer may be laminated on the surface of the solid preparation at least partially overlapping. Thereby, even when the area of the printable area is small, more information can be recorded on the surface of the solid preparation.
  • the latent image ink layer is preferably laminated on the visible ink layer. This makes it possible to irradiate the entire area of the latent image ink layer with ultraviolet rays when the ultraviolet rays are irradiated. As a result, the latent image can be visualized in a good state.
  • the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
  • the latent image aqueous ink composition used for forming the latent image ink layer according to the second embodiment the latent image aqueous ink composition used in the first embodiment can be used. Therefore, the detailed description is abbreviate
  • the visible ink aqueous ink composition used for forming the visible ink layer is not particularly limited, and a conventionally known aqueous ink composition containing at least one dye or pigment and having a main solvent as water can be used.
  • the water-based ink composition for visible images can be made edible by using a material that complies with the standards of pharmaceutical additives, Japanese pharmacopoeia, or food additives official regulations specified by the Pharmaceutical Affairs Law. In addition, it can be suitably used for recording an image or the like by an inkjet method.
  • the water-based ink composition for visible image is preferably visible under irradiation with visible light. Thereby, when the visible ink layer is formed using the visible image water-based ink containing the visible image water-based ink composition, identification by visual observation or the like is enabled.
  • the visible image water-based ink contains at least the visible image water-based ink composition.
  • a water-based ink composition for visible images that conforms to the standards of pharmaceutical additives, Japanese pharmacopoeia, or food additives official regulations stipulated by the Pharmaceutical Affairs Law
  • water-based inks for visible images are edible. Therefore, it is possible to print directly on the surface of a solid agent comprising tablets or capsules such as pharmaceuticals or supplements.
  • non-contact printing by an ink jet method is possible even for tablets with poor surface smoothness such as uncoated tablets and OD tablets.
  • the method for printing a solid preparation according to Embodiment 2 includes at least a visible image printing process for printing a visible image on the surface of the solid preparation, and a latent image printing process for printing a latent image on the surface of the solid preparation. .
  • the visible image printing step is a step of forming a visible image on the surface of the solid preparation by printing a visible ink layer using the visible image water-based ink.
  • a method for forming the visible ink layer is not particularly limited, but printing by an inkjet method is preferable. More specifically, the printing of the visible ink layer by the ink jet method is performed by ejecting the visible image water-based ink as droplets from a fine nozzle and attaching the droplets onto the solid preparation. There are no particular limitations on the method for ejecting the water-based ink for visible images.
  • a known method such as a continuous ejection type (charge control type, spray type, etc.), on-demand type (piezo type, thermal type, electrostatic suction type, etc.) Can be adopted.
  • Printing conditions such as ink droplet ejection amount and printing speed are not particularly limited, and can be set as necessary.
  • the visible image printing step may include a drying step of drying the droplets of the visible image water-based ink attached to the surface of the solid preparation. It does not specifically limit as a drying method, In addition to hot air drying, natural drying etc. can be performed. Also, drying conditions such as drying time and drying temperature are not particularly limited, and can be appropriately set according to the discharge amount of the droplets, the type of the aqueous ink composition for visible images, and the like.
  • the latent image printing step is a step of forming a latent image by printing a latent image ink layer on the surface of the solid preparation using the latent ink for latent images.
  • the method for forming the latent image ink layer is not particularly limited, but as in the case of the visible image printing step, printing by an ink jet method is preferable.
  • the printing of the latent image ink layer by the inkjet method is the same as that in the visible image printing step except that the latent image water-based ink is used.
  • the latent image printing step may include a drying step of drying the latent image aqueous ink droplets attached to the surface of the solid preparation. The drying method and drying conditions are the same as those in the visible image printing step.
  • the order of the visible image printing process and the latent image printing process is not particularly limited.
  • the latent image printing process is performed before the visible image printing process, the latent image may be printed in an area different from the scheduled printing area of the visible image.
  • the visible image printing area and the latent image printing area are at least partially overlapped on the surface of the solid preparation, first, after the visible image is printed in the visible image printing process, the latent image is printed in the latent image printing process. It is preferable to print.
  • the latent image ink layer can be laminated on the visible ink layer, and ultraviolet rays are emitted from the latent image when the latent image ink layer is visualized.
  • the entire area of the ink layer can be irradiated.
  • the solid pharmaceutical printing method may include the latent image visualization step.
  • the visualization step is a step that enables the latent image to be visualized by irradiating the latent image ink layer printed in the latent image printing step with light containing ultraviolet rays in a wavelength region of at least 100 nm to 400 nm.
  • the fluorescent agent uniformly contained in the latent image ink layer absorbs the ultraviolet rays and emits (fluoresces) light in the visible light region (380 nm to 760 nm). Thereby, the entire latent image ink layer in which the fluorescent agent is present emits fluorescence and is visualized.
  • the latent image ink layer before ultraviolet irradiation when the latent image ink layer before ultraviolet irradiation is colorless and transparent in the visible light region, the latent image ink layer can be visualized by fluorescence.
  • fluorescent dyes red No. 3, red No. 104, red No. 105 or red No. 106
  • basic dyes chlororophyll or rhodamine
  • the latent image ink layer before UV irradiation is colored in the visible light region.
  • the visibility is further improved by the fluorescence of the latent image ink layer.
  • Irradiation light used for visualization of the latent image is not particularly limited as long as it includes at least ultraviolet rays having a wavelength range of 100 nm to 400 nm. Therefore, in the visualization step, for example, it is possible to visualize the latent image using ultraviolet rays in the wavelength range in the presence of light in the visible range in the room.
  • most of the fluorescent agents used in the present embodiment have a maximum absorption wavelength in the range of 280 nm to 380 nm. For this reason, it is more preferable to include ultraviolet rays within a range of 280 nm to 380 nm in the light used for developing the latent image. Thereby, the ultraviolet absorption by the fluorescent agent is maximized, and the light intensity of the fluorescence emitted by the fluorescent agent can be further increased.
  • a filter with respect to the irradiation light.
  • a light emitting device that emits light including an ultraviolet region emits light in the visible light region in addition to the ultraviolet region. Therefore, if a filter or the like is used to block light other than the ultraviolet light in the wavelength range, the ultraviolet light is blocked by the filter as a result. As a result, the cumulative amount of ultraviolet light irradiated on the latent image ink layer. May also decrease. Thereby, the light intensity of the fluorescence emitted from the latent image ink layer may decrease.
  • the wavelength range of the ultraviolet rays contained in the irradiation light can be appropriately set according to the type of the fluorescent agent.
  • the integrated light amount (mJ / cm 2 ) of the irradiation light can be appropriately set according to the type of the fluorescent agent, the content in the latent image ink layer, the degree of photodegradability, and the like.
  • the latent image visualization step may include an observation step of observing the visualized latent image.
  • the observation method is not particularly limited, and imaging means such as a camera may be used in addition to visual observation.
  • the imaging means is not particularly limited, and can be appropriately selected according to the type of fluorescent agent or recording medium.
  • each material of the water-based ink composition for visible images and the water-based ink composition for latent images conforms to the standards of pharmaceutical additives, Japanese pharmacopoeia, or official food additives defined by the Pharmaceutical Affairs Law.
  • Example 1-1 As shown in Table 1 below, 0.01% by weight of red No. 3 as a fluorescent agent, 2% by weight of decaglyceryl caprylate (trade name: SY Glister MCA750, manufactured by Sakamoto Yakuhin Kogyo Co., Ltd.) as a surface tension adjuster, As a wetting agent, 30% by mass of propylene glycol and 67.9% by mass of pure water were mixed to prepare a latent image aqueous ink composition according to this example. The obtained aqueous ink composition for latent images was stored in a container that shields from ultraviolet rays (wavelength range: 100 nm to 400 nm) and visible light (400 nm to 760 nm).
  • ultraviolet rays wavelength range: 100 nm to 400 nm
  • visible light 400 nm to 760 nm
  • the latent image ink layer containing the latent image on the surface of the uncoated tablet is printed on one surface of the uncoated tablet by an inkjet recording method using the latent image aqueous ink composed of the latent image aqueous ink composition. (Printing process, see Table 2 below).
  • the latent image ink layer was light transmissive in the visible light region.
  • Printing was performed by a single pass (one pass) method using an inkjet printer (KC 600 dpi head, medium speed printing jig). Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface. Thus, a sample according to this example was produced.
  • the latent image ink layer printed on the surface of the uncoated tablet was irradiated with light containing ultraviolet rays having a wavelength range of 280 nm to 350 nm to cause the fluorescent agent contained in the latent image ink layer to fluoresce (visualization). Process).
  • the results are shown in Table 2 below. The visualization process was performed in a dark place.
  • Example 1-2 a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red 104 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
  • Example 1-3 a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red No. 105 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
  • Example 1-4 a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red 106 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
  • Example 1-5 aqueous latent ink for latent images was used in the same manner as in Example 1-1 except that 0.1% by mass of tryptophan was used as the fluorescent agent and the pure water content was changed to 67.9% by mass.
  • the composition was prepared, and printing on uncoated tablets was performed using the latent image aqueous ink composed of the latent image aqueous ink composition. The results are shown in Table 2 below.
  • Example 1-6 a latent image aqueous ink was used in the same manner as in Example 1-1 except that 0.1% by mass of quinine was used as the fluorescent agent and the pure water content was changed to 67.9% by mass.
  • the composition was prepared, and printing on uncoated tablets was performed using the latent image aqueous ink composed of the latent image aqueous ink composition. The results are shown in Table 2 below.
  • Example 2-1 Preparation of aqueous ink composition for visible image>
  • 4% by weight of edible dye 3 by weight of red No. 102, 1% by weight of No. 4 of yellow, 1% by weight of green No. 3
  • decaglyceryl caprylate trade name: SY Glyster MCA-750, manufactured by Sakamoto Yakuhin Kogyo Co., Ltd.
  • surface tension adjusting agent 30% by weight propylene glycol and 64% by weight pure water as a wetting agent
  • aqueous ink composition for latent image As shown in Table 3 below, 0.1% by mass of riboflavin sodium phosphate as a fluorescent agent, and 2% by mass of decaglyceryl caprylate as a surface tension adjuster (trade name: SY Glister MCA-750, Sakamoto Pharmaceutical Co., Ltd.) And 30 wt% propylene glycol as a wetting agent and 67.9 wt% pure water were mixed to prepare a yellow to orange yellow aqueous ink composition for latent images.
  • the obtained aqueous ink composition for latent images was stored in a container that shields from ultraviolet rays (wavelength range: 100 nm to 400 nm) and visible light (400 nm to 760 nm).
  • printing is performed on one surface of a sugar-coated tablet (sugar-coated layer is sucrose) by an inkjet method using the visible-image aqueous ink composed of the visible-image aqueous ink composition, and the sugar-coated tablet surface is coated with a visible ink layer.
  • a visible image was formed (visible image printing step, see Table 4 below). The visible ink layer was visible under irradiation with visible light.
  • Printing was performed by a single pass (one pass) method using an inkjet printer (KC 600 dpi head, medium speed printing jig). Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface.
  • ⁇ Latent image printing> printing is performed on the surface of the sugar-coated tablet on which the visible image is printed by using the latent-image aqueous ink composed of the latent-image aqueous ink composition, and the latent image containing the latent image on the sugar-coated tablet surface is printed.
  • An image ink layer was formed (latent image printing step, see Table 4 below).
  • the latent image print area was different from the visible image print area. Further, the latent image ink layer was light transmissive in the visible light region.
  • Printing was performed by a single pass method using the inkjet printer as in the case of the visible image printing process. Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface. Thereby, a printed matter of the solid preparation according to this example was produced.
  • Example 2-2 the water-based ink composition for latent images having the composition shown in Table 3 below was used.
  • the latent image was printed such that the latent image print area overlapped with the visible image print area.
  • FC tablets were used instead of sugar-coated tablets as solid preparations.
  • a printed material of the solid preparation according to this example was prepared in the same manner as in Example 2-1, except for these. Further, the latent image printed on the surface of the sugar-coated tablet was visualized by the same method as in Example 2-1. The results are shown in Table 4 below.

Abstract

Provided are: a latent image aqueous ink composition, where a latent image obtained thereby has suppressed visibility in the visible light region, and the aqueous ink composition is capable of developing the latent image after irradiation with ultraviolet rays; and a usage method and printing object thereof. This latent image aqueous ink composition is optically transparent in the visible light region and is used for printing a latent image, wherein: the latent image aqueous ink composition includes at least a fluorescent agent that emits fluorescence in the visible light region due to irradiation with ultraviolet rays having a wavelength region in the range of 100-400 nm; the fluorescent agent is at least one selected from the group consisting of riboflavin, a riboflavin butyric acid ester, a riboflavin sodium phosphate ester, a cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red no. 3, red no. 104, red no. 105, red no. 106, fumaric acid, chlorophyll, and rhodamine; and the fluorescent agent content is within a range of 0.001-10% by mass relative to the total mass of the latent image aqueous ink composition.

Description

潜像用水性インク組成物、使用方法及び印刷物、並びに固体製剤の印刷物及び固体製剤の印刷方法Aqueous ink composition for latent image, method of use and printed matter, and printed matter of solid formulation and printing method of solid formulation
 本発明は潜像用水性インク組成物、使用方法及び印刷物に関し、より詳細には、例えば、医薬品等の記録媒体に、可視光領域下では潜像であり、紫外線照射後では顕像化する画像を印刷することが可能な潜像用水性インク組成物、使用方法及び印刷物に関する。 The present invention relates to an aqueous ink composition for a latent image, a method of use, and a printed material. More specifically, for example, on a recording medium such as a pharmaceutical, an image that is a latent image in the visible light region and is visualized after ultraviolet irradiation. It is related with the aqueous ink composition for latent images which can print, and a usage method and printed matter.
 また、本発明は固体製剤の印刷物及び固体製剤の印刷方法に関し、より詳細には、医薬品や食品等の固体製剤に、紫外線照射により顕像化することが可能な潜像と、可視光照射下で視認が可能な可視画像が印刷された固体製剤の印刷物及び固体製剤の印刷方法に関する。 The present invention also relates to a printed matter of a solid preparation and a printing method of the solid preparation, and more specifically, to a solid preparation such as a pharmaceutical or food, a latent image that can be visualized by ultraviolet irradiation, and under visible light irradiation. The present invention relates to a printed matter of a solid preparation on which a visible image that can be visually recognized is printed, and a printing method of the solid preparation.
 近年、医薬品の偽造製品(偽造薬)が広まっていることに懸念が増大している。偽造製品は、正規製造業者の利益を悪化させるだけでなく、偽造製品と知らずに購入した消費者に健康被害をもたらす危険がある。そのため、医薬品の偽造製品が市場に出回るのを防止することが必要となっている。 In recent years, concerns have increased that counterfeit pharmaceutical products (counterfeit drugs) have become widespread. Counterfeit products not only exacerbate the profits of authorized manufacturers, but also pose a health hazard to consumers who buy without knowing that they are counterfeit products. For this reason, it is necessary to prevent counterfeit pharmaceutical products from entering the market.
 一方、錠剤やカプセル等の医薬品に対しては、スタンプ印刷や打刻印刷、インクジェット印刷等によって製品情報を直接印刷し、これにより使用者に医薬品の製品情報を目視により確認できる様にしている。例えば、口腔内崩壊性を有する錠剤に対し、直接印刷することが可能な可食性インクジェットインク組成物において、特許文献1では粒径10nm以上1μm以下の粒子からなるイカスミ色素を食用色素として用いることが開示されている。また、特許文献2では、当該可食性インクジェットインク組成物において、合成色素のアルミニウムレーキを食用色素として用いることが開示されている。さらに、特許文献3では、固形製剤の表面に画像を印刷するために、染料系食用色素のみで構成された水溶性インクを用いることが開示されている。 On the other hand, for pharmaceutical products such as tablets and capsules, product information is directly printed by stamp printing, stamp printing, ink jet printing, etc., so that the product information of the pharmaceutical products can be visually confirmed to the user. For example, in an edible ink-jet ink composition that can be directly printed on a tablet having an orally disintegrating property, Patent Document 1 uses a squid ink pigment composed of particles having a particle size of 10 nm or more and 1 μm or less as a food pigment. It is disclosed. Patent Document 2 discloses that the edible inkjet ink composition uses a synthetic dye aluminum lake as a food dye. Further, Patent Document 3 discloses that a water-soluble ink composed only of a dye-based food coloring is used to print an image on the surface of a solid preparation.
 しかし、これらの可食性インクジェットインク組成物を用いて錠剤等に製品情報を印刷した場合には、誰にでも当該製品情報を視認できるため、偽造者は、偽造製品にも同様の製品情報を印刷することが可能になる。その結果、従来の可食性インクジェットインク組成物を用いた製品情報の印刷は、正規品か否か確認することが困難な偽造製品の製造を容易にしている。また、OCR、OMR、バーコード及び二次元コード等の公知の光学読み取り方法においては、符号が印刷画線として視認可能なため、解読及び改竄の危険性も予想され、偽造、変造防止策として用いるには不十分である。その一方、製品情報の中には一般使用者に視認されても問題ない情報も含まれる。 However, when product information is printed on tablets or the like using these edible ink-jet ink compositions, anyone can view the product information, so counterfeiters print the same product information on counterfeit products. It becomes possible to do. As a result, the printing of product information using conventional edible inkjet ink compositions facilitates the production of counterfeit products that are difficult to confirm as genuine. In addition, in known optical reading methods such as OCR, OMR, barcode, and two-dimensional code, since the code is visible as a printed image line, there is a risk of decoding and tampering, and it is used as a measure for preventing forgery and alteration. Is not enough. On the other hand, the product information includes information that can be visually recognized by general users.
特開2015-81315号公報Japanese Patent Laying-Open No. 2015-81315 特開2012-111824号公報JP 2012-111824 A 特開2015-3883号公報Japanese Patent Laying-Open No. 2015-3883
 本発明は前記問題点に鑑みなされたものであり、その第1の目的は、可視光領域下では視認性を抑制した潜像であり、紫外線照射後では当該潜像を顕像化することが可能な潜像用水性インク組成物、使用方法及び印刷物を提供することにある。 The present invention has been made in view of the above-mentioned problems, and a first object thereof is a latent image in which visibility is suppressed under a visible light region, and the latent image is visualized after ultraviolet irradiation. It is an object to provide a latent aqueous ink composition for latent images, a method of use, and a printed matter.
 また、本発明の第2の目的は、可視光照射下では視認が困難であり、かつ、紫外線照射により顕像化することが可能な潜像と、可視光照射下で視認が可能な可視画像とを有する固体製剤の印刷物及び固体製剤の印刷方法を提供することにある。 In addition, the second object of the present invention is a latent image that is difficult to visually recognize under irradiation with visible light and can be visualized by irradiation with ultraviolet light, and a visible image that is visible under irradiation with visible light. It is providing the printed matter of a solid formulation which has these, and the printing method of a solid formulation.
 本発明に係る潜像用水性インク組成物は、前記の課題を解決する為に、可視光領域で光透過性を有し、潜像を印刷するための潜像用水性インク組成物であって、波長域が100nm~400nmの範囲の紫外線照射により可視光領域で蛍光を発する蛍光剤を少なくとも含み、前記蛍光剤が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種であり、前記蛍光剤の含有量が潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内であることを特徴とする。 The aqueous ink composition for a latent image according to the present invention is an aqueous ink composition for a latent image for printing a latent image, having light transmittance in a visible light region, in order to solve the above-described problems. At least a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and the fluorescent agent is riboflavin, riboflavin butyrate, sodium riboflavin phosphate, cinnamic acid derivative, L-tryptophan , Tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red 3, red 104, red 105, red 106, at least one selected from the group consisting of fumarate, chlorophyll and rhodamine The content of the fluorescent agent is 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images. Characterized in that it is in the range of.
 前記の構成の潜像用水性インク組成物(以下、「水性インク組成物」という場合がある。)は可視光領域において光透過性を有しているため、当該水性インク組成物を用いて、例えば、インクジェット方式で印刷した場合には、可視光領域の下で視認することが困難な潜像を印刷することができる。一方、前記構成の水性インク組成物は、100nm~400nmの波長域の紫外線照射により蛍光を発する蛍光剤を含むので、潜像からなる印刷画像に前記波長域の紫外線を含む光を照射した場合には、当該印刷画像を可視光領域下で顕像化させることができる。 Since the aqueous ink composition for latent images having the above structure (hereinafter sometimes referred to as “aqueous ink composition”) has light transmittance in the visible light region, the aqueous ink composition is used. For example, when printing is performed using an inkjet method, it is possible to print a latent image that is difficult to view under the visible light region. On the other hand, since the water-based ink composition having the above-described structure contains a fluorescent agent that emits fluorescence when irradiated with ultraviolet rays in a wavelength region of 100 nm to 400 nm, a printed image composed of a latent image is irradiated with light containing ultraviolet rays in the wavelength region. Can visualize the printed image under a visible light region.
 尚、前記の構成において、蛍光剤の含有量は水性インク組成物の全質量に対し0.001質量%~10質量%以下である。これにより、前記構成においては、可視光領域における光透過性を維持しながら潜像の印刷を可能にする。また、水性インク組成物中における蛍光剤の溶解性が過度に低下するのを防止し、インクジェットノズルからの吐出安定性を良好に維持して、飛翔性が低下するのを抑制することができる。 In the above-described configuration, the content of the fluorescent agent is 0.001% by mass to 10% by mass or less with respect to the total mass of the aqueous ink composition. Thereby, in the said structure, a latent image can be printed, maintaining the light transmittance in visible region. In addition, it is possible to prevent the solubility of the fluorescent agent in the aqueous ink composition from being excessively lowered, to maintain the ejection stability from the ink jet nozzles well, and to prevent the flying performance from being lowered.
 また前記の構成に於いては、前記潜像用水性インク組成物が、固体製剤に対するインクジェット方式での潜像の印刷に用いられるものであり、前記蛍光剤が可食性を有することが好ましい。本発明の水性インク組成物は、前記波長域の紫外線照射により顕像化することが可能な潜像を印刷可能にするものである。そのため、記録媒体として固体製剤を用い、これに製品情報等を潜像として印刷した場合、可視光領域下では製品情報等を視認することが困難になることから、偽造製品の製造も抑制することができる。そして、潜像として印刷された製品情報等の画像を確認したい場合や、製品の真贋等を確認したい場合には、潜像を含む印刷画像に紫外線を照射することによりこれを可視化することができる。 In the above-described configuration, it is preferable that the aqueous ink composition for a latent image is used for printing a latent image by an inkjet method on a solid preparation, and the fluorescent agent is edible. The water-based ink composition of the present invention makes it possible to print a latent image that can be visualized by irradiation with ultraviolet rays in the wavelength range. Therefore, when a solid preparation is used as a recording medium and product information is printed as a latent image on the recording medium, it becomes difficult to visually recognize the product information etc. under the visible light region, thus suppressing the production of counterfeit products. Can do. When it is desired to confirm an image such as product information printed as a latent image or to confirm the authenticity of a product, this can be visualized by irradiating the printed image including the latent image with ultraviolet rays. .
 また、本発明に係る潜像用水性インクの使用方法は、前記の課題を解決する為に、潜像用水性インク組成物を含む潜像用水性インクを用いて、記録媒体上に潜像を印刷する潜像用水性インクの使用方法であって、前記記録媒体の表面上に、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層を印刷して、前記潜像を形成する潜像印刷工程と、前記潜像インク層に、少なくとも100nm~400nmの波長域の紫外線を含む光を照射することにより、当該潜像インク層で可視光領域の蛍光を発生させ、前記潜像を顕像化させる顕像化工程とを含み、前記潜像用水性インク組成物として、波長域が100nm~400nmの範囲の紫外線照射により可視光領域で蛍光を発する蛍光剤を少なくとも含み、前記蛍光剤が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種であり、前記蛍光剤の含有量が潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内のものを用いることを特徴とする。 Further, in order to solve the above-mentioned problems, the method for using the latent image aqueous ink according to the present invention uses a latent image aqueous ink containing a latent image aqueous ink composition to form a latent image on a recording medium. A method of using a latent ink for printing a latent image, wherein the surface of the recording medium has a light-transmitting property with respect to visible light and is irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm. A latent image printing step of forming a latent image ink layer that emits fluorescence and irradiating the latent image ink layer with light containing ultraviolet rays in a wavelength region of at least 100 nm to 400 nm, The latent image ink layer generates fluorescence in the visible light region and visualizes the latent image, and the latent image water-based ink composition has a wavelength range of 100 nm to 400 nm. Visible light by UV irradiation A fluorescent agent that emits fluorescence in the region, and the fluorescent agent is riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, Quinine sulfate, Red No. 3, Red No. 104, Red No. 105, Red No. 106, at least one selected from the group consisting of fumarate, chlorophyll and rhodamine, and the content of the fluorescent agent is an aqueous ink for latent images A composition having a composition in the range of 0.001% by mass to 10% by mass with respect to the total mass of the composition is used.
 前記の構成によれば、潜像用水性インク(以下、「水性インク」という場合がある。)には、可視光領域下で光透過性を有する水性インク組成物を含むので、前記印刷工程では、可視光領域下で視認することが困難な潜像を含む潜像インク層を印刷することができる。さらに、水性インク組成物中には、100nm~400nmの波長域の紫外線照射により蛍光を発する蛍光剤を含むので、前記顕像化工程において、潜像インク層に少なくとも当該波長域の紫外線を含む光を照射することにより、潜像を可視光領域下で顕像化(可視化)させることができる。 According to the above-described configuration, the latent image water-based ink (hereinafter sometimes referred to as “water-based ink”) includes the water-based ink composition having light transmittance in the visible light region. In addition, it is possible to print a latent image ink layer including a latent image that is difficult to visually recognize in the visible light region. Further, since the aqueous ink composition contains a fluorescent agent that emits fluorescence when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm, in the visualization step, the latent image ink layer contains light containing at least ultraviolet rays in the wavelength range. , The latent image can be visualized (visualized) in the visible light region.
 前記構成に於いては、前記記録媒体として固体製剤を用いることができる。本発明の使用方法は、前記波長域の紫外線照射により顕像化することが可能な潜像を印刷する工程を含むものである。そのため、記録媒体として固体製剤を用い、これに製品情報等を潜像として印刷した場合、可視光領域下では製品情報等を視認することが困難になることから、偽造製品の製造も抑制することができる。そして、潜像として印刷された製品情報等の画像を確認したい場合や、製品の真贋等を確認したい場合には、潜像を含む印刷画像に紫外線を照射することにより、これを可視化することができる。 In the above configuration, a solid preparation can be used as the recording medium. The method of use of the present invention includes a step of printing a latent image that can be visualized by irradiation with ultraviolet rays in the wavelength range. Therefore, when a solid preparation is used as a recording medium and product information is printed as a latent image on the recording medium, it becomes difficult to visually recognize the product information etc. under the visible light region, thus suppressing the production of counterfeit products. Can do. If you want to check the product information image printed as a latent image, or if you want to check the authenticity of the product, you can visualize this by irradiating the printed image containing the latent image with ultraviolet rays. it can.
 また、本発明に係る印刷物は、前記の課題を解決する為に、記録媒体の表面の少なくとも一部に潜像が設けられた印刷物であって、前記潜像は、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層からなり、前記潜像インク層が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種の蛍光剤を含むことを特徴とする。 In order to solve the above problems, the printed material according to the present invention is a printed material in which a latent image is provided on at least a part of the surface of the recording medium, and the latent image is light transmissive to visible light. And a latent image ink layer that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and the latent image ink layer is riboflavin, riboflavin butyrate, sodium riboflavin phosphate Cinnamic acid derivatives, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red 3, red 104, red 105, red 106, fumarate, chlorophyll and rhodamine It includes at least one fluorescent agent selected from the group consisting of:
 前記の構成によれば、記録媒体上に設けられている潜像インク層は可視光領域下で光透過性を有しており、潜像を含むものであるので、当該可視光領域下での視認を困難にすることができる。そして、潜像インク層には、100nm~400nmの波長域の紫外線照射により蛍光を発することが可能な蛍光剤が含まれているので、前記構成の印刷物であると、前記紫外線を含む光を照射して潜像インク層で蛍光を発生させることにより、潜像を含む潜像インク層を顕像化することができる。 According to the above configuration, the latent image ink layer provided on the recording medium has light transmittance under the visible light region and includes a latent image. Can be difficult. Since the latent image ink layer contains a fluorescent agent capable of emitting fluorescence when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm, the printed matter having the above structure is irradiated with light containing the ultraviolet rays. By generating fluorescence in the latent image ink layer, the latent image ink layer including the latent image can be visualized.
 前記構成に於いては、前記記録媒体を固体製剤とすることができる。これにより、潜像を含む潜像インク層により製品情報を印刷した場合には、可視光領域下での視認が困難なため、当該製品情報を印刷した偽造製品の製造を困難にすることができる。また、潜像インク層に紫外線を照射することにより当該潜像インク層により形成された製品情報を容易に顕像化することができるため、印刷された製品情報を確認して調剤ミス等の発生を抑制できると共に、製品の真贋も確認することができる。 In the above configuration, the recording medium can be a solid preparation. As a result, when product information is printed with a latent image ink layer containing a latent image, it is difficult to visually recognize under the visible light region, so that it is possible to make it difficult to manufacture a counterfeit product on which the product information is printed. . In addition, the product information formed by the latent image ink layer can be easily visualized by irradiating the latent image ink layer with ultraviolet rays, so the printed product information can be confirmed and dispensing errors can occur. Can be suppressed, and the authenticity of the product can be confirmed.
 また、本発明に係る固体製剤の印刷物は、前記の課題を解決する為に、表面の少なくとも一部に、潜像と可視画像が設けられた固体製剤の印刷物であって、前記潜像は、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層からなり、前記可視画像は、可視光照射下で視認可能な可視インク層からなることを特徴とする。 Further, in order to solve the above problems, a printed matter of a solid preparation according to the present invention is a printed matter of a solid preparation in which a latent image and a visible image are provided on at least a part of the surface. Consists of a latent image ink layer that is transparent to visible light and emits fluorescence in the visible light region when irradiated with ultraviolet light in the wavelength range of 100 nm to 400 nm. The visible image is visible under visible light irradiation. It consists of a possible visible ink layer.
 前記の構成によれば、固体製剤の表面の少なくとも一部には、潜像インク層からなる潜像と、可視インク層からなる可視画像が設けられている。前記潜像インク層は可視光に対し光透過性を有するため、当該潜像インク層からなる潜像は可視光の照射下において視認することが困難となっている。また、潜像インク層は100nm~400nmの波長域の紫外線照射により可視光領域の蛍光を発するため、当該潜像インク層からなる潜像は前記紫外線の照射下において顕像化(可視化)し、良好に視認することができる。一方、前記可視インク層は可視光の照射下において視認することが可能であるため、当該可視インク層からなる可視画像も当該可視光の照射下において良好に視認することができる。従って、前記構成の固体製剤の印刷物であると、情報の内容等に応じて潜像又は可視画像として情報を固体製剤表面に記録することが可能になり、情報の記録方法の自由度を向上させることができる。 According to the above configuration, a latent image composed of the latent image ink layer and a visible image composed of the visible ink layer are provided on at least a part of the surface of the solid preparation. Since the latent image ink layer has a light-transmitting property with respect to visible light, it is difficult to visually recognize the latent image made of the latent image ink layer under irradiation of visible light. Further, since the latent image ink layer emits fluorescence in the visible light region when irradiated with ultraviolet rays in a wavelength range of 100 nm to 400 nm, the latent image formed of the latent image ink layer is visualized (visualized) under the irradiation of the ultraviolet rays, It can be visually recognized well. On the other hand, since the visible ink layer can be viewed under irradiation with visible light, a visible image made of the visible ink layer can be viewed well under irradiation with visible light. Therefore, when the solid preparation is a printed matter having the above-described configuration, it becomes possible to record information on the surface of the solid preparation as a latent image or a visible image according to the content of the information, and the degree of freedom of the information recording method is improved. be able to.
 前記の構成においては、前記潜像インク層が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種の蛍光剤を含むことが好ましい。 In the above configuration, the latent image ink layer is composed of riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, It is preferable to include at least one fluorescent agent selected from the group consisting of Red No. 3, Red No. 104, Red No. 105, Red No. 106, fumarate, chlorophyll and rhodamine.
 また、前記の構成においては、前記潜像インク層が潜像用水性インクの乾燥被膜からなり、前記潜像用水性インクが、前記蛍光剤を含む潜像用水性インク組成物を含むものであり、前記蛍光剤の含有量が前記水性コーティング組成物の全質量に対し0.001質量%~10質量%の範囲内であることが好ましい。 Further, in the above configuration, the latent image ink layer is formed of a dry film of a latent image aqueous ink, and the latent image aqueous ink includes the latent image aqueous ink composition containing the fluorescent agent. The content of the fluorescent agent is preferably in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous coating composition.
 前記の構成によれば、潜像インク層は、潜像用水性インク(以下、「水性インク」という場合がある。)を用いて印刷された、当該水性インクの乾燥被膜からなるものとすることができる。そして、水性インクに含まれる潜像用水性インク組成物(以下、「水性インク組成物」という場合がある。)においては、前記蛍光剤を当該水性インク組成物の全質量に対し0.001質量%~10質量%の範囲で含有するので、可視光領域における光透過性を維持しながら潜像の印刷を可能にする。また、水性インク組成物中における蛍光剤の溶解性が過度に低下するのを防止するので、例えば、インクジェット方式により潜像インク層を印刷する場合には、インクジェットノズルからの吐出安定性を良好に維持して、飛翔性が低下するのを抑制することができる。 According to the above configuration, the latent image ink layer is made of a dry film of the water-based ink printed using the latent image water-based ink (hereinafter sometimes referred to as “water-based ink”). Can do. In the aqueous ink composition for latent images contained in the aqueous ink (hereinafter sometimes referred to as “aqueous ink composition”), the fluorescent agent is added in an amount of 0.001 mass relative to the total mass of the aqueous ink composition. Since it is contained in the range of 10% to 10% by weight, it is possible to print a latent image while maintaining light transmittance in the visible light region. In addition, since the solubility of the fluorescent agent in the aqueous ink composition is prevented from excessively decreasing, for example, when printing a latent image ink layer by an inkjet method, the ejection stability from the inkjet nozzle is improved. It can maintain and can suppress that flying property falls.
 さらに前記の構成において、前記可視インク層と潜像インク層は、前記表面上の異なる領域にそれぞれ設けられ、又は前記表面上に少なくとも一部重複した状態で順次積層されていてもよい。潜像インク層と可視インク層を、固体製剤の表面上のそれぞれ異なる領域に形成する場合には、前記紫外線の照射により顕像化された潜像と可視画像とが重複して視認されるのを防止することができる。また、潜像インク層と可視インク層を、少なくとも一部重複した状態で積層する場合には、固体製剤上の印刷可能な領域の面積が小さいときにも、より多くの情報を当該固体製剤表面に記録することが可能になる。 Further, in the above-described configuration, the visible ink layer and the latent image ink layer may be provided in different regions on the surface, or may be sequentially stacked on the surface at least partially overlapping each other. When the latent image ink layer and the visible ink layer are formed in different regions on the surface of the solid preparation, the latent image visualized by the irradiation of the ultraviolet ray and the visible image are visually recognized. Can be prevented. In addition, when the latent image ink layer and the visible ink layer are laminated in a state where at least part of them overlap, more information can be obtained even when the area of the printable region on the solid preparation is small. Can be recorded.
 尚、可視インク層と潜像インク層を少なくとも一部重複した状態で積層する場合には、潜像インク層は可視インク層上に積層される。これにより、前記紫外線の照射による顕像化の際に、潜像インク層の全領域に紫外線を照射させることができ、潜像を良好な状態で顕像化することができる。また、潜像インク層は可視光領域において光透過性を有するため、可視光照射下における可視画像の視認性の低下を抑制することができる。 In the case where the visible ink layer and the latent image ink layer are laminated in a state where at least a part thereof overlaps, the latent image ink layer is laminated on the visible ink layer. As a result, the entire area of the latent image ink layer can be irradiated with ultraviolet rays at the time of visualization by irradiation with the ultraviolet rays, and the latent image can be visualized in a good state. In addition, since the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
 また、本発明に係る固体製剤の印刷方法は、前記の課題を解決する為に、固体製剤の表面の少なくとも一部に、潜像及び可視画像を印刷する固体製剤の印刷方法であって、前記固体製剤の表面上に、可視光照射下で視認可能な可視インク層を印刷して、前記可視画像を形成する可視画像印刷工程と、前記可視画像の印刷領域とは異なる領域、当該可視画像の印刷予定領域とは異なる領域、又は当該可視画像の印刷領域と少なくとも一部重複する領域に、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層を印刷して、前記潜像を形成する潜像印刷工程とを含むことを特徴とする。 Further, the solid preparation printing method according to the present invention is a solid preparation printing method for printing a latent image and a visible image on at least a part of the surface of the solid preparation in order to solve the above-mentioned problems, On the surface of the solid preparation, a visible ink layer that is visible under irradiation with visible light is printed to form the visible image, a visible image printing region, a region different from the visible image printing region, An area that is different from the area to be printed or an area that at least partially overlaps the visible image printing area has optical transparency to visible light and is visible by irradiation with ultraviolet rays having a wavelength range of 100 nm to 400 nm. A latent image printing step of printing a latent image ink layer that emits fluorescence in the light region to form the latent image.
 前記の構成によれば、可視画像印刷工程においては、固体製剤の表面に、可視光照射下での視認が可能な可視インク層を印刷し、これにより可視画像を形成する。また、潜像印刷工程においては、固体製剤の表面に、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層を形成する。これにより、可視光の照射下では視認することが困難であり、前記波長域の紫外線の照射下では、蛍光を発することにより顕像化することが可能な潜像を形成することができる。 According to the above configuration, in the visible image printing step, the visible ink layer that is visible under visible light irradiation is printed on the surface of the solid preparation, thereby forming a visible image. Further, in the latent image printing step, the latent image ink has a light-transmitting property with respect to visible light on the surface of the solid preparation and emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm. Form a layer. Thereby, it is difficult to visually recognize under irradiation of visible light, and a latent image that can be visualized by emitting fluorescence can be formed under irradiation of ultraviolet rays in the wavelength range.
 ここで、潜像印刷工程における潜像インク層の印刷を、可視画像の印刷領域とは異なる領域、又は当該可視画像の印刷予定領域とは異なる領域に行う場合には、前記紫外線の照射により顕像化された潜像と、可視画像とが重複して視認されるのを防止することができる。また、潜像インク層の印刷を、可視画像の印刷領域と少なくとも一部重複する領域に行う場合には、固体製剤上の印刷可能な領域の面積が小さいときに、より多くの情報を当該固体製剤表面に記録することができる。尚、潜像インク層の印刷を、可視画像の印刷領域と少なくとも一部重複する領域に行う場合、当該潜像インク層は可視インク層上に一部積層するように印刷される。これにより、前記紫外線の照射による顕像化の際に、潜像インク層の全領域に紫外線を照射させることができ、潜像を良好な状態で顕像化することができる。また、潜像インク層は可視光領域において光透過性を有するため、可視光照射下における可視画像の視認性の低下も抑制することができる。 Here, when printing of the latent image ink layer in the latent image printing step is performed in an area different from the print area of the visible image or an area different from the print scheduled area of the visible image, the latent image ink layer is exposed by the irradiation of the ultraviolet rays. It is possible to prevent the visualized latent image and the visible image from being visually recognized. In addition, when the latent image ink layer is printed in an area at least partially overlapping the print area of the visible image, more information is obtained when the area of the printable area on the solid preparation is small. Can be recorded on the formulation surface. Note that when the latent image ink layer is printed in an area at least partially overlapping the visible image print area, the latent image ink layer is printed so as to be partially laminated on the visible ink layer. As a result, the entire area of the latent image ink layer can be irradiated with ultraviolet rays at the time of visualization by irradiation with the ultraviolet rays, and the latent image can be visualized in a good state. In addition, since the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
 また、前記の構成においては、前記潜像印刷工程は、潜像用水性インク組成物を含む潜像用水性インクを用いて、インクジェット方式により前記潜像インク層の印刷を行う工程であり、前記潜像用水性インク組成物は、波長域が100nm~400nmの範囲の紫外線の照射により可視光領域の蛍光を発する蛍光剤を含み、かつ、可視光領域で光透過性を有するものであることが好ましい。潜像インク層を印刷するための潜像用水性インクとして、可視光領域で光透過性を有する潜像用水性インク組成物を含むものを用いることにより、可視光の照射下で視認することが困難な潜像インク層を形成することができる。また、前記潜像用水性インク組成物に前記蛍光剤を含むものを用いることにより、前記紫外線の照射により可視光領域の蛍光を発生して顕像化することが可能な潜像インク層を形成することができる。 Further, in the above configuration, the latent image printing step is a step of printing the latent image ink layer by an inkjet method using a latent image aqueous ink containing a latent image aqueous ink composition, The aqueous ink composition for latent images contains a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and has light transmittance in the visible light region. preferable. As a latent image aqueous ink for printing a latent image ink layer, by using a latent image water-based ink composition having light transmittance in the visible light region, the latent image ink layer can be visually recognized under irradiation with visible light. A difficult latent image ink layer can be formed. Also, a latent image ink layer that can be visualized by generating fluorescence in the visible light region upon irradiation with the ultraviolet rays is formed by using the aqueous ink composition for latent images containing the fluorescent agent. can do.
 前記の構成に於いては、前記蛍光剤として、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種を用いることが好ましい。 In the above structure, the fluorescent agent includes riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, It is preferable to use at least one selected from the group consisting of Red No. 3, Red No. 104, Red No. 105, Red No. 106, fumarate, chlorophyll and rhodamine.
 前記の構成に於いては、前記蛍光剤の含有量が前記潜像用水性インク組成物の全質量に対し0.001質量%~10質量%であることが好ましい。 In the above configuration, the content of the fluorescent agent is preferably 0.001% by mass to 10% by mass with respect to the total mass of the latent image water-based ink composition.
 水性インクとして、潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内の蛍光剤を含むものを用いることにより、可視光領域での光透過性を維持しながら潜像を印刷することが可能になる。また、潜像用水性インク組成物中における蛍光剤の溶解性が過度に低下するのを防止し、インクジェットノズルからの吐出安定性を良好に維持して、飛翔性が低下するのを抑制することができる。 By using a water-based ink containing a fluorescent agent in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images, light transmittance in the visible light region is maintained. It becomes possible to print the latent image. In addition, the solubility of the fluorescent agent in the latent ink composition for the latent image is prevented from excessively decreasing, and the ejection stability from the ink jet nozzle is well maintained, and the flying property is suppressed from decreasing. Can do.
 本発明の潜像用水性インク組成物は、可視光領域での光透過性を有すると共に、波長域が100nm~400nmの紫外線照射により蛍光を発する蛍光剤を含む。従って、例えば、本発明の潜像用水性インク組成物をインクジェット方式での印刷に用いた場合には、可視光領域下では視認が困難であり、前記紫外線を照射した後は、蛍光を発することにより顕像化することが可能な潜像を印刷画像として印刷することができる。これにより、例えば、固体製剤への製品情報等の印刷に本発明の潜像用水性インク組成物を用いた場合には、偽造製品の製造を防止することが可能になる。また、製品情報等を確認して調剤等を行う場合や製品の真贋を確認したい場合には、少なくとも100nm~400nmの波長域の紫外線を含む光を照射することにより容易に印刷画像を顕像化することができるという効果を奏する。 The aqueous ink composition for latent images of the present invention contains a fluorescent agent that has optical transparency in the visible light region and emits fluorescence when irradiated with ultraviolet rays having a wavelength region of 100 nm to 400 nm. Therefore, for example, when the aqueous ink composition for latent images of the present invention is used for printing in an ink jet system, it is difficult to visually recognize under the visible light region, and emits fluorescence after being irradiated with the ultraviolet rays. Thus, a latent image that can be visualized can be printed as a print image. Thereby, for example, when the aqueous ink composition for latent images of the present invention is used for printing product information on a solid preparation, it becomes possible to prevent the production of counterfeit products. In addition, if you want to check the product information, etc. to make preparations, or if you want to check the authenticity of the product, print images can be easily visualized by irradiating light containing ultraviolet rays in the wavelength range of at least 100 nm to 400 nm. There is an effect that can be done.
 また、本発明の固体製剤の印刷物によれば、可視光照射下で視認可能な可視インク層からなる可視画像と、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層からなる潜像とを有する構成を採用する。そのため、例えば、視認されても問題ない製品情報等については可視画像として印刷し、調剤や製品の真贋の確認等に必要な製品情報等については潜像として印刷するなどして、情報の記録の自由度を向上させた固体製剤の印刷物を提供することができる。 In addition, according to the printed matter of the solid preparation of the present invention, a visible image composed of a visible ink layer that is visible under irradiation with visible light, light transmittance with respect to visible light, and a wavelength range of 100 nm to 400 nm. A configuration having a latent image composed of a latent image ink layer that emits fluorescence in the visible light region when irradiated with ultraviolet rays in a range is employed. For this reason, for example, product information that can be visually recognized is printed as a visible image, and product information necessary for confirmation of preparation or product authenticity is printed as a latent image. It is possible to provide a printed matter of a solid preparation with an improved degree of freedom.
 さらに、本発明の固体製剤の印刷方法によれば、固体製剤の表面に、情報の内容等に応じて、潜像又は可視画像に使い分けながら情報を記録することが可能であり、情報の記録方法の自由度を向上させることが可能な固体製剤の印刷方法を提供することができる。 Furthermore, according to the method for printing a solid preparation of the present invention, it is possible to record information on the surface of the solid preparation, depending on the content of the information, etc., while properly using the latent image or visible image. It is possible to provide a method for printing a solid preparation capable of improving the degree of freedom.
[実施の形態1]
 (潜像用水性インク組成物及び潜像用水性インク)
 本実施の形態1に係る潜像用水性インク組成物について、以下に説明する。
 本実施の形態1の潜像用水性インク組成物は、少なくとも蛍光剤を含み、主溶媒を水とする組成物である。また、本実施の形態1の潜像用水性インク組成物は、薬事法で定める医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合した材料を用いることにより、可食性を有するものにすることができ、かつ、インクジェット方式での画像等の記録に好適に用いることができる。
[Embodiment 1]
(Latent image water-based ink composition and latent image water-based ink)
The latent image aqueous ink composition according to Embodiment 1 will be described below.
The aqueous ink composition for latent images of the first embodiment is a composition containing at least a fluorescent agent and using water as a main solvent. In addition, the latent image aqueous ink composition of the first embodiment has edible properties by using a material that complies with the standards of pharmaceutical additives, Japanese Pharmacopoeia or Food Additives specified by the Pharmaceutical Affairs Law. And can be suitably used for recording an image or the like by an inkjet method.
 本明細書において「可食性」とは、医薬品若しくは医薬品添加物として経口投与が認められている物質、及び/又は食品若しくは食品添加物として認められているものを意味する。また、本明細書において「インクジェット方式」とは、潜像用水性インク組成物を含む潜像用水性インク等を微細なインクジェットヘッドより液滴として吐出して、その液滴を記録媒体に定着させ、画像形成させる方式を意味する。尚、記録媒体の詳細については、後述する。 As used herein, “edible” means a substance that is approved for oral administration as a pharmaceutical product or pharmaceutical additive and / or a food product or food additive. Further, in this specification, the “inkjet method” means that a latent image aqueous ink containing a latent image aqueous ink composition is ejected as droplets from a fine inkjet head, and the droplets are fixed on a recording medium. Means a method of forming an image. Details of the recording medium will be described later.
 潜像用水性インク組成物は、可視光領域(400nm~760nm)での光透過性を有していることが好ましい。これにより、当該潜像用水性インク組成物を含む潜像用水性インクを用いて潜像インク層を形成した場合には、当該潜像インク層の可視光に対する光透過性を付与することができる。尚、潜像用水性インク組成物が有する光透過性は無色である場合の他、有色であってもよい。また、本明細書において「光透過性」とは、入射した可視光の少なくとも一部を透過する性質を意味する。 The latent ink composition for latent images preferably has a light transmittance in the visible light region (400 nm to 760 nm). As a result, when the latent image ink layer is formed using the latent image aqueous ink containing the latent image aqueous ink composition, the latent image ink layer can be provided with a light-transmitting property with respect to visible light. . The light transmittance of the latent ink composition for a latent image may be colored as well as colorless. In the present specification, “light-transmitting” means a property of transmitting at least a part of incident visible light.
 前記蛍光剤は、波長域が100nm~400nmの範囲の紫外線(励起光)が照射された場合に、当該紫外線を吸収して可視光領域(380nm~760nm)に波長変換し蛍光を発する成分であり、具体的には、例えば、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム等のビタミンB群;桂皮酸メチル、桂皮酸エチル等の桂皮酸誘導体;L-トリプトファン、チロシン、フェニルアラニン等のアミノ酸;キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ等のキニーネ類;赤色3号、赤色104号、赤色105号、赤色106号等の有色の蛍光染料;フマル酸二ナトリウム、フマル酸一ナトリウム等のフマル酸(アルカリ金属)塩;クロロフィル、ローダミン等の塩基性染料、ミツロウ等が挙げられる。これらの蛍光剤は1種単独で、又は2種以上を混合して用いることができる。 The fluorescent agent is a component that, when irradiated with ultraviolet rays (excitation light) having a wavelength range of 100 nm to 400 nm, absorbs the ultraviolet rays and converts the wavelength into the visible light range (380 nm to 760 nm) to emit fluorescence. Specifically, for example, vitamin B group such as riboflavin, riboflavin butyrate and sodium riboflavin phosphate; cinnamic acid derivatives such as methyl cinnamate and ethyl cinnamate; amino acids such as L-tryptophan, tyrosine and phenylalanine; quinine Quinine hydrochlorides such as quinine hydrochloride dihydrate and quinine sulfate; colored fluorescent dyes such as red 3, red 104, red 105 and red 106; fumarate such as disodium fumarate and monosodium fumarate Acid (alkali metal) salts; basic dyes such as chlorophyll and rhodamine, beeswax etc. . These fluorescent agents can be used alone or in combination of two or more.
 前記に挙げた蛍光剤のうち、桂皮酸メチル、桂皮酸エチル、L-トリプトファン、チロシン、フェニルアラニン、フマル酸(アルカリ金属)塩は無色透明であり、これら以外の蛍光剤は有色透明である。 Among the fluorescent agents listed above, methyl cinnamate, ethyl cinnamate, L-tryptophan, tyrosine, phenylalanine, and fumaric acid (alkali metal) salts are colorless and transparent, and other fluorescent agents are colored and transparent.
 また、前記に列挙した蛍光剤のうち、蛍光を発生させて顕像化させた際の視認性を良好にするとの観点からは、リボフラビンリン酸エステルナトリウム、赤色3号、赤色104号、赤色106号が好ましい。また、インクジェットヘッドからの良好な吐出性能を確保するとの観点からは、リボフラビン、リボフラビンリン酸エステルナトリウム、L-トリプトファン、赤色104号、赤色106号が好ましい。 Among the fluorescent agents listed above, riboflavin phosphate sodium, red No. 3, red No. 104, red 106 from the viewpoint of improving visibility when fluorescence is generated and visualized. No. is preferred. From the standpoint of ensuring good ejection performance from the inkjet head, riboflavin, riboflavin phosphate sodium ester, L-tryptophan, red No. 104, and red No. 106 are preferable.
 ここで本明細書において「蛍光」とは、前記紫外線照射中に蛍光剤が発する可視光の他、紫外線照射終了後においても蛍光剤から発する残光のうち減衰時間の短い成分の可視光も含む意味である。また、前記減衰時間とは、蛍光剤の発光開始から基底状態に戻る(蛍光が消失する)までの遷移に要する時間を意味する。 In this specification, “fluorescence” includes visible light emitted from the fluorescent agent during the ultraviolet irradiation, and visible light having a short decay time among the afterglow emitted from the fluorescent agent even after the ultraviolet irradiation is completed. Meaning. The decay time means the time required for the transition from the start of light emission of the fluorescent agent to the return to the ground state (fluorescence disappears).
 また、本実施の形態の潜像用水性インク組成物を固体製剤への印刷に用いる場合には、蛍光剤は可食性を有することが好ましい。さらに、潜像インク層を顕像化して印刷画像の視認を良好にするとの観点からは、蛍光剤としては前記減衰時間が比較的長く、蓄光性を有するものが好ましい。これにより、紫外線照射の終了後においても、蛍光剤が発する残光を確認することで、顕像化した印刷画像の視認性を向上させることができる。 In addition, when the latent ink composition for latent images of the present embodiment is used for printing on a solid preparation, the fluorescent agent is preferably edible. Further, from the viewpoint of visualizing the printed image by visualizing the latent image ink layer, it is preferable that the fluorescent agent has a relatively long decay time and has a luminous property. Thereby, even after the end of ultraviolet irradiation, the visibility of the visualized printed image can be improved by confirming the afterglow emitted by the fluorescent agent.
 前記蛍光剤の含有量は、当該蛍光剤が無色透明のものである場合、潜像用水性インク組成物の全質量に対し0.001質量%~10質量%であることが好ましく、0.05質量%~2質量%の範囲内であることがより好ましい。また、蛍光剤が有色透明のものである場合、潜像用水性インク組成物の全質量に対し0.001質量%~10質量%であることが好ましく、0.01質量%~1質量%の範囲内であることがより好ましい。蛍光剤の含有量を10質量%以下にすることにより、潜像として印刷された画像が視認され難くすることができる。その一方、蛍光剤の含有量を0.001質量%以上にすることにより、紫外線照射後に潜像インク層を顕像化しても視認し難くなるのを防止することができる。尚、蛍光剤の含有量は、前記数値範囲内において、潜像インク層を形成したときの印刷画像の視認性、及び蛍光を発生させたときの潜像インク層の視認性等を考慮して、前記に挙げた蛍光剤の種類毎に設定されるのが好ましい。 When the fluorescent agent is colorless and transparent, the content of the fluorescent agent is preferably 0.001% by mass to 10% by mass with respect to the total mass of the latent ink aqueous ink composition. More preferably, it is within the range of 2% by mass to 2% by mass. Further, when the fluorescent agent is colored and transparent, it is preferably 0.001% by mass to 10% by mass, and preferably 0.01% by mass to 1% by mass with respect to the total mass of the latent image aqueous ink composition. More preferably within the range. By setting the content of the fluorescent agent to 10% by mass or less, it is possible to make it difficult to visually recognize an image printed as a latent image. On the other hand, by setting the content of the fluorescent agent to 0.001% by mass or more, it is possible to prevent the latent image ink layer from becoming difficult to visually recognize even after the ultraviolet irradiation. In addition, the content of the fluorescent agent is within the numerical range, considering the visibility of the printed image when the latent image ink layer is formed, the visibility of the latent image ink layer when the fluorescence is generated, and the like. It is preferable to set for each type of fluorescent agent mentioned above.
 本実施の形態の潜像用水性インク組成物においては、蛍光を発しない染料が配合されていてもよい。そのような染料としては、例えば、アゾ系染料、トリフェニルメタン系染料等が挙げられる。前記アゾ系染料としては特に限定されず、例えば、赤色102号、赤色40号、黄色4号、黄色5号等が挙げられる。前記トリフェニルメタン系染料としては特に限定されず、例えば、青色1号、緑色3号等が挙げられる。さらに、コチニール色素、銅クロロフィリンナトリウム、カカオ色素、カラメル色素等の食用天然色素を併用することも可能である。これらの染料は、薬事法で定める医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合したものであり、用途等に応じて適宜選択することができる。 In the latent image aqueous ink composition of the present embodiment, a dye that does not emit fluorescence may be blended. Examples of such dyes include azo dyes and triphenylmethane dyes. The azo dye is not particularly limited, and examples thereof include Red No. 102, Red No. 40, Yellow No. 4, Yellow No. 5, and the like. The triphenylmethane dye is not particularly limited, and examples thereof include blue No. 1 and green No. 3. Furthermore, it is also possible to use edible natural pigments such as cochineal pigment, copper chlorophyllin sodium, cacao pigment and caramel pigment together. These dyes comply with the standards of pharmaceutical additives, Japanese pharmacopoeia or official food additives specified by the Pharmaceutical Affairs Law, and can be appropriately selected according to the use.
 また、本実施の形態の潜像用水性インク組成物においては、その他の添加剤が配合されていてもよい。その他の添加剤としては、表面張力調整剤、湿潤剤、水溶性樹脂、有機アミン、界面活性剤、pH調整剤、キレート化剤、防腐剤、粘度調整剤、消泡剤等が挙げられる。本実施の形態の潜像用水性インク組成物を食品製剤や医薬製剤等の固体製剤表面への印刷に用いる場合には、これらの他の添加剤は、薬事法で定める医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合するものであることが好ましい。尚、表面張力調整剤及び湿潤剤を除き、これらの添加剤の含有量は特に限定されず、適宜必要に応じて設定することができる(表面張力調整剤及び湿潤剤の含有量については、それぞれ後述する。)。 Further, in the aqueous image composition for latent images of the present embodiment, other additives may be blended. Examples of other additives include surface tension adjusting agents, wetting agents, water-soluble resins, organic amines, surfactants, pH adjusting agents, chelating agents, preservatives, viscosity adjusting agents, and antifoaming agents. When the aqueous ink composition for latent images of the present embodiment is used for printing on the surface of solid preparations such as food preparations and pharmaceutical preparations, these other additives are pharmaceutical additives specified by the Pharmaceutical Affairs Law, Japan Pharmacy It is preferable that it complies with the standard of the method or food additive official standard. In addition, the content of these additives is not particularly limited except for the surface tension adjusting agent and the wetting agent, and can be appropriately set as necessary (for the contents of the surface tension adjusting agent and the wetting agent, respectively. (It will be described later.)
 前記表面張力調整剤としては特に限定されず、具体的には、例えば、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル等が挙げられる。前記グリセリン脂肪酸エステルとしては、例えば、カプリル酸デカグリセリル、ラウリン酸ヘキサグリセリンエステル、オレイン酸ヘキサグリセリンエステル、縮合リノレン酸テトラグリセリンエステル、脂肪酸エステルヤシパーム、HLBが15以下のラウリン酸デカグリセリル、HLBが13未満のオレイン酸デカグリセリル等が挙げられる。これらは一種単独で、又は二種以上を混合して用いてもよい。尚、例示した前記表面張力調整剤は何れも薬事法等の基準に適合するものであるので、固体製剤への印刷にも適用可能である。 The surface tension adjusting agent is not particularly limited, and specific examples include glycerin fatty acid esters and polyglycerin fatty acid esters. Examples of the glycerin fatty acid ester include caprylic acid decaglyceryl, lauric acid hexaglycerin ester, oleic acid hexaglycerin ester, condensed linolenic acid tetraglycerin ester, fatty acid ester palm palm, lauric acid decaglyceryl having an HLB of 15 or less, and HLB. Examples include decaglyceryl oleate of less than 13. You may use these individually by 1 type or in mixture of 2 or more types. In addition, since all of the exemplified surface tension adjusting agents conform to standards such as the Pharmaceutical Affairs Law, they can be applied to printing on solid preparations.
 前記カプリル酸デカグリセリルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、リョートー(登録商標)ポリグリエステル CE19D(商品名、三菱化学フーズ(株)製、HLB値15)、SYグリスターMCA750(商品名、阪本薬品工業(株)製、HLB値16)等が挙げられる。 As the caprylic acid decaglyceryl, it is possible to use a commercially available product. Examples of such a commercially available product include Ryoto (registered trademark) polyglycerate CE19D (trade name, manufactured by Mitsubishi Chemical Foods Co., Ltd., HLB). Value 15), SY glister MCA750 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 16), and the like.
 尚、前記HLBの値は、グリフィン法によるHLB値であり、下記式によって得られる値を意味する。
 HLB値=20×(親水基の式量の和/分子量)
 HLB値は0~20の範囲内の値となり、HLB値が大きいほど親水性が強くなり、HLB値が小さいほど疎水性が強くなる。
The HLB value is an HLB value according to the Griffin method and means a value obtained by the following equation.
HLB value = 20 × (sum of formula weight of hydrophilic group / molecular weight)
The HLB value is a value in the range of 0 to 20. The larger the HLB value, the stronger the hydrophilicity, and the smaller the HLB value, the stronger the hydrophobicity.
 前記ラウリン酸デカグリセリルとしては、HLBが15以下のものを用いることができる。HLBが15を超えるラウリン酸デカグリセリルであると、インクジェットヘッドのノズルの目詰まりに起因してかすれ等が発生するなど、吐出安定性が低下する。HLBの下限は、水溶媒に対する溶解度の観点からは、10以上であることが好ましい。また、HLBが15以下のラウリン酸デカグリセリルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、NIKKOL(登録商標) DECAGLYN 1-L(商品名、日光ケミカルズ(株)製、HLB値14.5)、SYグリスターML-750(商品名、阪本薬品工業(株)製、HLB値14.8)等が挙げられる。 As the decaglyceryl laurate, those having an HLB of 15 or less can be used. When the decaglyceryl laurate has an HLB of more than 15, the ejection stability is lowered, for example, the occurrence of fading due to clogging of the nozzles of the inkjet head. The lower limit of HLB is preferably 10 or more from the viewpoint of solubility in an aqueous solvent. Further, as decaglyceryl laurate having an HLB of 15 or less, a commercially available product can be used. Examples of such a commercially available product include NIKKOL (registered trademark) DECAGLYN 1-L (trade name, Nikko Chemicals ( HLB value 14.5), SY Glister ML-750 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 14.8), and the like.
 前記オレイン酸デカグリセリルとしては、HLBが13未満のものを用いることができる。HLBが13以上であると、インクジェットヘッドのノズルの目詰まりに起因してかすれ等が発生するなど、吐出安定性が低下する。尚、HLBの下限は、水溶媒に対する溶解度の観点からは、10以上であることが好ましい。また、HLBが13未満のオレイン酸デカグリセリルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、NIKKOL(登録商標) DECAGLYN 1-OV(商品名、日光ケミカルズ(株)製、HLB値12)、SYグリスターMO-7S(商品名、阪本薬品工業(株)製、HLB値12.9)等が挙げられる。 As the decaglyceryl oleate, those having an HLB of less than 13 can be used. When the HLB is 13 or more, the ejection stability is deteriorated, such as blurring due to clogging of the nozzles of the inkjet head. In addition, it is preferable that the minimum of HLB is 10 or more from a viewpoint of the solubility with respect to a water solvent. Further, as decaglyceryl oleate having an HLB of less than 13, a commercially available product can be used. Examples of such a commercially available product include NIKKOL (registered trademark) DECAGLYN 1-OV (trade name, Nikko Chemicals ( Co., Ltd., HLB value 12), SY Glister MO-7S (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 12.9), and the like.
 前記ラウリン酸ヘキサグリセリンエステルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、NIKKOL(登録商標) HEXAGLYN 1-L(商品名、日光ケミカルズ(株)製、HLB値14.5)、SYグリスターML-500(商品名、阪本薬品工業(株)製、HLB値13.5)等が挙げられる。 As the lauric acid hexaglycerin ester, a commercially available product can be used, and as such a commercially available product, for example, NIKKOL (registered trademark) HEXAGLYN 1-L (trade name, manufactured by Nikko Chemicals Co., Ltd., HLB) Value 14.5), SY Glister ML-500 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 13.5), and the like.
 前記オレイン酸ヘキサグリセリンエステルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、SYグリスターMO-5S(商品名、阪本薬品工業(株)製、HLB値11.6)等が挙げられる。 Commercially available products can be used as the oleic acid hexaglycerin ester. Examples of such commercially available products include SY Glyster MO-5S (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd., HLB value 11. 6) and the like.
 前記縮合リノレン酸テトラグリセリンエステルとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、SYグリスターCR-310(商品名、阪本薬品工業(株)製)等が挙げられる。 Commercially available products can be used as the condensed linolenic acid tetraglycerin ester. Examples of such commercially available products include SY Glyster CR-310 (trade name, manufactured by Sakamoto Pharmaceutical Co., Ltd.). It is done.
 脂肪酸エステルヤシパームとしては、市販品を用いることが可能であり、そのような市販品としては、例えば、チラバゾールW-01(商品名、太陽化学(株)製)等が挙げられる。 As the fatty acid ester palm palm, a commercially available product can be used, and examples of such a commercially available product include Tirabazole W-01 (trade name, manufactured by Taiyo Kagaku Co., Ltd.).
 表面張力調整剤の含有量は、潜像用水性インク組成物の全質量に対し、0.1質量%~5質量%の範囲内であることが好ましく、1質量%~2質量%の範囲内であることがより好ましい。表面張力調整剤の含有量が0.1質量%以上であると、インクジェット方式で印刷を行った場合に、インクジェットヘッドにおけるノズルでのメニスカス形成不良等による吐出不良を防止し、当該ノズルの目詰まりが発生するのを防止することができる。その結果、吐出安定性の向上が図れる。その一方、表面張力調整剤の含有量が5質量%以下であると、表面張力調整剤の不溶分や乳化不良による吐出への悪影響を防止することができる。 The content of the surface tension adjusting agent is preferably within a range of 0.1% by mass to 5% by mass with respect to the total mass of the aqueous ink composition for latent images, and within a range of 1% by mass to 2% by mass. It is more preferable that When the content of the surface tension adjusting agent is 0.1% by mass or more, when printing is performed by an inkjet method, ejection failure due to meniscus formation failure or the like at the nozzle in the inkjet head is prevented, and the nozzle is clogged. Can be prevented. As a result, the discharge stability can be improved. On the other hand, when the content of the surface tension adjusting agent is 5% by mass or less, it is possible to prevent an adverse effect on discharge due to insoluble matter or poor emulsification of the surface tension adjusting agent.
 前記湿潤剤としては特に限定されず、具体的には、例えば、ポリエチレングリコール、プロピレングリコール、グリセリン等が挙げられる。尚、これらの湿潤剤は薬事法等の基準に適合するものであるので、固体製剤への印刷にも適用可能である。 The wetting agent is not particularly limited, and specific examples include polyethylene glycol, propylene glycol, glycerin and the like. In addition, since these wetting agents meet standards such as the Pharmaceutical Affairs Law, they can also be applied to printing on solid preparations.
 前記湿潤剤の添加量は、潜像用水性インク組成物の全質量に対し、1質量%~50質量%が好ましく、10質量%~40質量%がより好ましい。湿潤剤の含有量を1質量%以上にすることにより、インクジェットヘッドのノズル近傍での目詰まりを防止し、吐出性能の一層の向上が図れる。その一方、湿潤剤の含有量を50質量%以下にすることにより、潜像用水性インク組成物の粘度を適性に制御することができる。 The amount of the wetting agent added is preferably 1% by mass to 50% by mass, and more preferably 10% by mass to 40% by mass with respect to the total mass of the latent image aqueous ink composition. By setting the content of the wetting agent to 1% by mass or more, clogging in the vicinity of the nozzle of the inkjet head can be prevented, and the ejection performance can be further improved. On the other hand, by setting the content of the wetting agent to 50% by mass or less, the viscosity of the latent image aqueous ink composition can be appropriately controlled.
 本実施の形態の潜像用水性インク組成物に於いては、水(主溶媒としての水)を含有する。前記水としては、イオン交換水、限外ろ過水、逆浸透水、蒸留水等の純水、又は超純水等のイオン性不純物を除去したものを用いるのが好ましい。特に、紫外線照射又は過酸化水素添加等により滅菌処理した水は、長期間にわたってカビやバクテリアの発生を防止することができるので好適である。また、水の含有量としては特に限定されず、適宜必要に応じて設定することができる。 The latent image aqueous ink composition of the present embodiment contains water (water as a main solvent). As the water, it is preferable to use water from which ionic impurities such as ion-exchanged water, ultrafiltered water, reverse osmosis water, distilled water, or ultrapure water have been removed. In particular, water sterilized by ultraviolet irradiation or addition of hydrogen peroxide is preferable because generation of mold and bacteria can be prevented over a long period of time. Moreover, it does not specifically limit as content of water, It can set suitably as needed.
 潜像用水性インク組成物の粘度は、インクジェットノズルからの吐出安定性を考慮すると、インクジェットノズル吐出時において、2mPa・s~6mPa・sが好ましく、3mPa・s~5mPa・sがより好ましい。潜像用水性インク組成物の粘度を前記数値範囲内にすることにより、インクジェットノズルでの目詰まりの発生を抑制して良好な吐出安定性の維持を図ることができ、飛翔性の低下を抑制することができる。尚、潜像用水性インク組成物の粘度は、例えば、粘度計(商品名:VISCOMATE MODEL VM-10A、(株)セコニック製)を用いて、測定温度25℃の条件下で測定することにより得られる。 The viscosity of the latent ink composition for a latent image is preferably 2 mPa · s to 6 mPa · s, more preferably 3 mPa · s to 5 mPa · s at the time of ink jet nozzle ejection, in consideration of ejection stability from the ink jet nozzle. By setting the viscosity of the aqueous ink composition for latent images within the above-mentioned numerical range, it is possible to suppress clogging at the ink jet nozzle and maintain good ejection stability, and to suppress a decrease in flying performance. can do. The viscosity of the latent image water-based ink composition is obtained, for example, by measuring the viscosity at a measurement temperature of 25 ° C. using a viscometer (trade name: VISCOMATE MODEL VM-10A, manufactured by Seconic Corporation). It is done.
 本実施の形態の潜像用水性インク組成物は、前述の各成分を適宜な方法で混合することよって製造することができる。混合方法及び添加順序は特に限定されない。混合後は、十分に撹拌し、必要に応じて目詰まりの原因となる粗大粒子及び異物を除去するための濾過を行う。これにより、本実施の形態に係る潜像用水性インク組成物を得ることができる。 The aqueous ink composition for latent images of the present embodiment can be produced by mixing the above-described components by an appropriate method. The mixing method and the order of addition are not particularly limited. After mixing, the mixture is sufficiently stirred, and if necessary, filtration is performed to remove coarse particles and foreign matters that cause clogging. Thereby, the aqueous ink composition for latent images according to the present embodiment can be obtained.
 各材料の混合方法としては特に限定されず、例えば、ディスパー、メカニカルスターラー、マグネチックスターラー等の撹拌装置を備えた容器に順次材料を添加して撹拌混合を行うことができる。また、濾過方法としては特に限定されず、例えば、遠心濾過、フィルター濾過等を採用することができる。 The mixing method of each material is not particularly limited, and for example, the materials can be sequentially added to a container equipped with a stirring device such as a disper, a mechanical stirrer, or a magnetic stirrer to perform stirring and mixing. Moreover, it does not specifically limit as a filtration method, For example, centrifugal filtration, filter filtration, etc. are employable.
 尚、潜像用水性インク組成物の保管は、少なくとも紫外線(波長域100nm~400nm)を遮光することが可能な遮光性を有する容器を用いて行うのが好ましい。これにより、潜像用水性インク組成物中の蛍光剤が光分解するのを抑制し、長期にわたって保存することが可能になる。遮光性を有する容器としては特に限定されず、アルミニウム製の容器や着色容器、紫外線吸収剤を含む合成樹脂製の容器など、従来公知のものを採用することができる。 The storage of the latent ink for a latent image is preferably performed using a light-shielding container capable of shielding at least ultraviolet rays (wavelength range of 100 nm to 400 nm). This suppresses photodegradation of the fluorescent agent in the aqueous ink composition for latent images, and can be stored for a long period of time. The light-shielding container is not particularly limited, and a conventionally known container such as an aluminum container, a colored container, or a synthetic resin container containing an ultraviolet absorber can be used.
 本実施の形態の潜像用水性インクは、前述の潜像用水性インク組成物を少なくとも含む。特に、薬事法等で定められている医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合した蛍光剤等を含む潜像用水性インク組成物を用いた場合には、潜像用水性インクは可食性を有しているので、医薬品又はサプリメント等の錠剤やカプセル剤からなる固体性剤の表面に直接印刷することが可能である。また、素錠及びOD錠など表面の平滑性が悪い錠剤に対しても、インクジェット方式による非接触印刷を可能にする。尚、潜像用水性インクの保管方法については、前述の潜像用水性インク組成物の場合と同様である。 The latent image aqueous ink of the present embodiment includes at least the above-described latent image aqueous ink composition. In particular, when using a latent ink for a latent image containing a pharmaceutical additive stipulated by the Pharmaceutical Affairs Law, a fluorescent agent that conforms to the standards of the Japanese Pharmacopoeia or the Food Additives Standard, etc. Since the water-based ink is edible, it can be directly printed on the surface of a solid agent comprising tablets or capsules such as pharmaceuticals or supplements. In addition, non-contact printing by an ink jet method is possible even for tablets with poor surface smoothness such as uncoated tablets and OD tablets. The method for storing the latent image water-based ink is the same as that of the above-described latent image water-based ink composition.
 (潜像用水性インクの使用方法)
 本実施の形態1の潜像用水性インクの使用方法は、潜像を含む潜像インク層を印刷する印刷工程と、当該潜像インク層に紫外線を照射し、潜像を顕像化(可視化)させる顕像化工程とを少なくとも含む。
(Usage method of aqueous ink for latent image)
The method of using the latent ink for latent image according to the first embodiment includes a printing process for printing a latent image ink layer including a latent image, and irradiating the latent image ink layer with ultraviolet rays to visualize (visualize) the latent image. At least a visualization step.
 前記潜像インク層の印刷工程は、インクジェット方式により記録媒体上に潜像インク層を印刷し形成する工程である。より具体的には、微細なノズルより、潜像用水性インク組成物を含む潜像用水性インクを液滴として吐出し、その液滴を記録媒体上に付着させることにより行う。潜像用水性インクの吐出方法として特に限定されず、例えば、連続噴射型(荷電制御型、スプレー型等)、オンデマンド型(ピエゾ方式、サーマル方式、静電吸引方式等)等の公知の方法を採用することができる。インク滴の吐出量、印刷速度等の印刷条件は特に限定されず、適宜必要に応じて設定することができる。 The printing process of the latent image ink layer is a process of printing and forming the latent image ink layer on the recording medium by an ink jet method. More specifically, the latent image aqueous ink containing the latent image aqueous ink composition is ejected as droplets from a fine nozzle, and the droplets are deposited on a recording medium. There are no particular limitations on the method of discharging the latent image water-based ink. For example, a known method such as a continuous ejection type (charge control type, spray type, etc.), on-demand type (piezo type, thermal type, electrostatic suction type, etc.) Can be adopted. Printing conditions such as ink droplet ejection amount and printing speed are not particularly limited, and can be set as necessary.
 また、印刷工程には、固体製剤の表面に付着したインク滴を乾燥させる乾燥工程を含む。乾燥方法としては特に限定されず、熱風乾燥の他、自然乾燥等を行うことができる。また、乾燥時間や乾燥温度等の乾燥条件についても特に限定されず、インク滴の吐出量や潜像用水性インク組成物の種類等に応じて適宜設定することができる。 In addition, the printing process includes a drying process for drying ink droplets attached to the surface of the solid preparation. It does not specifically limit as a drying method, In addition to hot air drying, natural drying etc. can be performed. Also, the drying conditions such as drying time and drying temperature are not particularly limited, and can be appropriately set according to the ejection amount of ink droplets, the type of the latent image aqueous ink composition, and the like.
 前記潜像の顕像化工程は、印刷工程で印刷された潜像インク層に、少なくとも100nm~400nmの波長域の紫外線を含む光を照射することにより、印刷画像の可視化を可能にする工程である。紫外線の照射により、潜像インク層中に均一に含まれる蛍光剤が当該紫外線を吸収し、可視光領域(380nm~760nm)の光を発光(蛍光)する。これにより、蛍光剤が存在する潜像インク層全体が蛍光を発して可視化する。 The latent image visualization step is a step that enables visualization of a printed image by irradiating the latent image ink layer printed in the printing step with light containing ultraviolet rays in a wavelength region of at least 100 nm to 400 nm. is there. When irradiated with ultraviolet rays, the fluorescent agent uniformly contained in the latent image ink layer absorbs the ultraviolet rays and emits (fluoresces) light in the visible light region (380 nm to 760 nm). Thereby, the entire latent image ink layer in which the fluorescent agent is present emits fluorescence and is visualized.
 ここで、紫外線照射前の潜像インク層が可視光領域で無色透明である場合には、当該潜像インク層の蛍光により可視化が可能になる。また、蛍光剤として蛍光染料(赤色3号、赤色104号、赤色105号又は赤色106号)や塩基性染料(クロロフィル又はローダミン)を用い、紫外線照射前の潜像インク層が可視光領域で有色透明である場合には、潜像インク層の蛍光により視認性が一層向上する。 Here, when the latent image ink layer before ultraviolet irradiation is colorless and transparent in the visible light region, the latent image ink layer can be visualized by fluorescence. In addition, fluorescent dyes (red No. 3, red No. 104, red No. 105 or red No. 106) and basic dyes (chlorophyll or rhodamine) are used as fluorescent agents, and the latent image ink layer before UV irradiation is colored in the visible light region. When it is transparent, the visibility is further improved by the fluorescence of the latent image ink layer.
 潜像の顕像化に用いる照射光は、波長域が100nm~400nmの範囲の紫外線を少なくとも含むものであれば特に限定されない。従って、顕像化工程は、例えば、室内において可視光領域の光が存在する中で前記波長域の範囲の紫外線を用いて潜像の可視化を行うことも可能である。尚、本実施の形態で用いる蛍光剤の多くは、280nm~380nmの範囲で吸収波長の極大値を有している。そのため、潜像の顕像化に用いる光には、280nm~380nmの範囲内の紫外線を含めるのがより好ましい。これにより、蛍光剤による紫外線吸収を極大化し、当該蛍光剤が発する蛍光の光強度を一層大きくすることができる。 Irradiation light used for visualization of the latent image is not particularly limited as long as it includes at least ultraviolet rays having a wavelength range of 100 nm to 400 nm. Therefore, in the visualization step, for example, it is possible to visualize the latent image using ultraviolet rays in the wavelength range in the presence of light in the visible range in the room. Note that most of the fluorescent agents used in the present embodiment have a maximum absorption wavelength in the range of 280 nm to 380 nm. For this reason, it is more preferable to include ultraviolet rays within a range of 280 nm to 380 nm in the light used for developing the latent image. Thereby, the ultraviolet absorption by the fluorescent agent is maximized, and the light intensity of the fluorescence emitted by the fluorescent agent can be further increased.
 また、照射光に対しては、例えば、フィルター等を用いて、100nm~400nmの範囲の紫外線以外の光を遮断する必要はない。一般的に販売されている紫外線領域を含んだ光を発する発光機は、紫外線領域以外に可視光領域の光も同時に照射する。そのため、フィルター等を用いて、前記波長域の紫外線以外の光を遮断しようとした場合には、当該紫外線も少なからずフィルターに遮断されてしまう結果、潜像インク層に照射される紫外線の積算光量も減少する場合がある。これにより、潜像インク層が発する蛍光の光強度が低下する場合がある。 In addition, it is not necessary to block light other than ultraviolet rays in the range of 100 nm to 400 nm using, for example, a filter with respect to the irradiation light. In general, a light emitting device that emits light including an ultraviolet region emits light in the visible light region in addition to the ultraviolet region. Therefore, if a filter or the like is used to block light other than the ultraviolet light in the wavelength range, the ultraviolet light is blocked by the filter as a result. As a result, the cumulative amount of ultraviolet light irradiated on the latent image ink layer. May also decrease. Thereby, the light intensity of the fluorescence emitted from the latent image ink layer may decrease.
 また、照射光に含まれる紫外線の波長域は、蛍光剤の種類に応じて適宜設定することができる。また、照射光の積算光量(mJ/cm)は、蛍光剤の種類や潜像インク層中の含有量、光分解性の程度等に応じて適宜設定することができる。 Moreover, the wavelength range of the ultraviolet rays contained in the irradiation light can be appropriately set according to the type of the fluorescent agent. Further, the integrated light amount (mJ / cm 2 ) of the irradiation light can be appropriately set according to the type of the fluorescent agent, the content in the latent image ink layer, the degree of photodegradability, and the like.
 尚、潜像の顕像化工程においては、顕像化された印刷画像を観察する観察工程を含んでもよい。観察方法としては特に限定されず、目視の他、カメラ等の撮像手段を用いてもよい。撮像手段としては特に限定されず、蛍光剤や記録媒体の種類等に応じて適宜選択することができる。 Note that the latent image visualization step may include an observation step of observing the visualized printed image. The observation method is not particularly limited, and imaging means such as a camera may be used in addition to visual observation. The imaging means is not particularly limited, and can be appropriately selected according to the type of fluorescent agent or recording medium.
 (印刷物)
 本実施の形態1の印刷物は、記録媒体上に、潜像を含む潜像インク層が少なくとも設けられている。本実施の形態の潜像用水性インクで印刷された潜像インク層は、当該潜像用水性インクの乾燥皮膜からなり、可視光領域で光透過性を有している。そして乾燥皮膜は、潜像用水性インク組成物中に含まれていた蛍光剤により少なくとも構成される。蛍光剤は、潜像インク層(潜像用水性インクの乾燥皮膜)中に均一に存在している。
(Printed matter)
In the printed matter of the first embodiment, at least a latent image ink layer including a latent image is provided on a recording medium. The latent image ink layer printed with the latent image water-based ink of the present embodiment is made of a dry film of the latent image water-based ink and has light transmittance in the visible light region. The dry film is composed of at least a fluorescent agent contained in the latent image aqueous ink composition. The fluorescent agent is uniformly present in the latent image ink layer (dried film of the latent image aqueous ink).
 本明細書において潜像インク層とは、潜像用水性インクの乾燥皮膜を含むものであり、少なくとも印刷画像の一部を形成するものである。印刷画像には潜像の他、可視光領域下において目視等で視認可能な画像も含まれる。また、印刷画像の種類は特に限定されず、絵柄、文字、模様及びこれらの組み合わせ等が挙げられ、記録媒体が固体製剤である場合には、印刷画像は当該文字等により表された製品情報として表される。 In this specification, the latent image ink layer includes a dry film of a latent image aqueous ink and forms at least a part of a printed image. In addition to the latent image, the printed image includes an image that can be visually recognized under the visible light region. In addition, the type of the print image is not particularly limited, and examples thereof include a pattern, characters, patterns, and combinations thereof. When the recording medium is a solid preparation, the print image is the product information represented by the characters. expressed.
 潜像インク層は、前述の通り、可視光領域で光透過性を有している。ここで、本明細書において「光透過性」とは、入射した可視光の少なくとも一部を透過する性質を意味する。より具体的には、厚さ2μmの潜像インク層に対し、波長域が400nm~800nmの可視光の透過率が、潜像インク層が存在しない場合に対し、50%以上であり、好ましくは70%以上、より好ましくは90%以上の場合である。 As described above, the latent image ink layer has light transmittance in the visible light region. As used herein, “light transmissive” means a property of transmitting at least part of incident visible light. More specifically, the transmittance of visible light having a wavelength range of 400 nm to 800 nm is 50% or more with respect to the latent image ink layer having a thickness of 2 μm, preferably 50% or more, preferably The case is 70% or more, more preferably 90% or more.
 潜像インク層の(乾燥塗布後の)厚さは特に限定されず、潜像用水性インクの組成や印刷速度、潜像用水性インクの液滴の定着性及び乾燥速度等を考慮して適宜設定することができる。 The thickness of the latent image ink layer (after dry coating) is not particularly limited, and is appropriately determined in consideration of the composition and printing speed of the latent image aqueous ink, the fixability of the droplets of the latent image aqueous ink, the drying speed, and the like. Can be set.
 前記記録媒体としては特に限定されず、従来公知のものを採用することができる。具体的には、例えば、アート紙、コート紙、及びマット紙等の印刷用紙が挙げられる。また、記録媒体として固体製剤に適用することもできる。尚、本明細書において、「固体製剤」とは食品製剤及び医薬製剤を含む意味であり、固体製剤の形態としては、例えばOD錠(口腔内崩壊錠)、素錠、FC(フィルムコート)錠、糖衣錠等の錠剤又はカプセル剤が挙げられる。また、固体製剤は、医薬品用途であってもよく、食品用途であってもよい。食品用途の錠剤の例としては、錠菓やサプリメント等の健康食品が挙げられる。固体製剤のうち、前記錠剤は常温下において固体状であり、例えば、有効成分を含む錠剤材料を一定の形状に圧縮及び/又は成形により製造されたものが好ましい。錠剤の形状は特に限定されず、任意の形状を採用することができる。記録媒体として固体製剤に適用した場合には、製品情報など使用者に対し識別性を向上させるために印刷した各種情報の印刷画像の劣化を防止することが可能になることから、長期にわたって良好な視認性を維持し、調剤ミスや誤飲の防止を可能にした固体製剤を提供することができる。 The recording medium is not particularly limited, and a conventionally known recording medium can be used. Specific examples include printing paper such as art paper, coated paper, and matte paper. Further, it can be applied to a solid preparation as a recording medium. In the present specification, the term “solid preparation” includes food preparations and pharmaceutical preparations. Examples of solid preparation forms include OD tablets (orally disintegrating tablets), plain tablets, and FC (film coat) tablets. And tablets or capsules such as sugar-coated tablets. The solid preparation may be used for pharmaceuticals or food. Examples of tablets for food use include health foods such as tablet confectionery and supplements. Among solid preparations, the tablet is solid at room temperature, and for example, a tablet prepared by compressing and / or molding a tablet material containing an active ingredient into a certain shape is preferable. The shape of the tablet is not particularly limited, and any shape can be adopted. When applied to a solid preparation as a recording medium, it is possible to prevent deterioration of the printed image of various information printed to improve identification for the user such as product information. It is possible to provide a solid preparation that maintains visibility and prevents dispensing errors and accidental ingestion.
[実施の形態2]
 (固体製剤の印刷物)
 本実施の形態2に係る固体製剤の印刷物について、以下に説明する。
 本実施の形態2の固体製剤の印刷物は、表面の少なくとも一部に潜像と可視画像を有する。「固体製剤」の意味については前述の通りである。
[Embodiment 2]
(Printed product of solid preparation)
The printed matter of the solid preparation according to the second embodiment will be described below.
The printed matter of the solid preparation of the second embodiment has a latent image and a visible image on at least a part of the surface. The meaning of “solid preparation” is as described above.
 また、本明細書において「潜像」とは、可視光(波長域400nmより大きく760nm以下)が照射された環境下においては識別が困難であり、特定の条件下において顕像化する画像を意味する。さらに、本明細書において「可視画像」とは、可視光(波長域400nm~760nm)が照射された環境下においては識別可能な画像を意味する。ここで、潜像又は可視画像として印刷される画像は、例えば、インクジェット用の水性インクを用いてインクジェット方式等により印刷可能である。 Further, in this specification, the “latent image” means an image that is difficult to distinguish under an environment irradiated with visible light (wavelength range of greater than 400 nm and less than 760 nm) and is visualized under a specific condition. To do. Further, in this specification, the “visible image” means an image that can be identified in an environment irradiated with visible light (wavelength range: 400 nm to 760 nm). Here, the image printed as a latent image or a visible image can be printed by, for example, an inkjet method using an aqueous inkjet ink.
 前記潜像は潜像インク層からなる。潜像インク層としては、インクジェット方式での印刷に適用可能な潜像用水性インク(詳細については、実施の形態1で述べた通りである。)の乾燥皮膜からなるものが好ましい。乾燥皮膜は、前記潜像用水性インクを用いて、例えばインクジェット方式等により固体製剤表面に直接印刷することにより形成することができる。 The latent image is composed of a latent image ink layer. The latent image ink layer is preferably composed of a dry film of an aqueous ink for latent images applicable to inkjet printing (details are as described in Embodiment 1). The dry film can be formed by directly printing on the surface of the solid preparation using the latent ink for latent images, for example, by an inkjet method or the like.
 潜像インク層は、可視光領域(400nmより大きく760nm以下)で光透過性を有している。これにより、可視光照射下での潜像インク層の視認を困難にすることができる。ここで、本明細書において「光透過性」とは、入射した可視光の少なくとも一部を透過する性質を意味する。より具体的には、厚さ2μmの潜像インク層に対し、波長域が400nm~760nmの可視光の透過率が、潜像インク層が存在しない場合に対し、50%以上であり、好ましくは70%以上、より好ましくは90%以上の場合である。また光透過性には、潜像インク層が無色である場合の他、有色である場合も含む意味である。 The latent image ink layer has optical transparency in the visible light region (greater than 400 nm and less than 760 nm). This makes it difficult to visually recognize the latent image ink layer under visible light irradiation. As used herein, “light transmissive” means a property of transmitting at least part of incident visible light. More specifically, the transmittance of visible light having a wavelength range of 400 nm to 760 nm is 50% or more with respect to the latent image ink layer having a thickness of 2 μm, preferably 50% or more, preferably The case is 70% or more, more preferably 90% or more. In addition, the term “light transmissivity” means that the latent image ink layer is colored as well as colored.
 また、潜像インク層には蛍光剤が含まれており、これにより潜像インク層は波長域が100nm~400nmの範囲の紫外線が照射されたときに可視光領域の蛍光を発する。 In addition, the latent image ink layer contains a fluorescent agent, whereby the latent image ink layer emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
 潜像インク層の(乾燥塗布後の)厚さは特に限定されず、潜像用水性インクの組成や印刷速度、潜像用水性インクの液滴の定着性及び乾燥速度等を考慮して適宜設定することができる。 The thickness of the latent image ink layer (after dry coating) is not particularly limited, and is appropriately determined in consideration of the composition and printing speed of the latent image aqueous ink, the fixability of the droplets of the latent image aqueous ink, the drying speed, and the like. Can be set.
 前記可視画像は可視インク層からなる。可視インク層は、可視光照射下において視認可能なインク層である。また、可視インク層は、インクジェット方式での印刷に適用可能な可視画像用水性インク(詳細について、後述する。)の乾燥皮膜からなるものが好ましい。乾燥皮膜は、前記可視画像用水性インクを用いて、例えばインクジェット方式等により固体製剤表面に直接印刷することにより形成することができる。 The visible image is composed of a visible ink layer. The visible ink layer is an ink layer that is visible under visible light irradiation. The visible ink layer is preferably composed of a dry film of a water-based ink for visible images (details will be described later) that can be applied to printing by an inkjet method. The dry film can be formed by printing directly on the surface of the solid preparation using the above-described aqueous ink for visible images, for example, by an ink jet method.
 前記潜像インク層と可視インク層は、固体製剤の表面上の異なる領域にそれぞれ設けることができる。例えば固体製剤が円盤形又はレンズ形の錠剤である場合には、一方の面に潜像インク層を設け、他方の面に可視インク層を設ける等することができる。潜像インク層と可視インク層の印刷領域を相互に異ならせることにより、可視光領域の蛍光を発することにより顕像化された潜像と、可視画像が重複して視認されるのを防止し、視認性の低下を抑制することができる。 The latent image ink layer and the visible ink layer can be provided in different areas on the surface of the solid preparation. For example, when the solid preparation is a disc-shaped or lens-shaped tablet, a latent image ink layer can be provided on one side and a visible ink layer can be provided on the other side. By making the print areas of the latent image ink layer and the visible ink layer different from each other, it is possible to prevent the visible image and the latent image visualized by emitting fluorescence in the visible light region from being overlapped. , Visibility can be suppressed.
 また、前記潜像インク層と可視インク層は、固体製剤の表面上に少なくとも一部重複した状態で積層させてもよい。これにより、印刷可能な領域の面積が小さい場合にも、より多くの情報を固体製剤表面に記録することが可能になる。尚、潜像インク層と可視インク層を少なくとも一部重複した状態で積層する場合、潜像インク層は可視インク層上に積層されるのが好ましい。これにより、前記紫外線の照射の際に、潜像インク層の全領域を紫外線に照射させることが可能になる。その結果、潜像を良好な状態で顕像化することができる。また、潜像インク層は可視光領域において光透過性を有するため、可視光照射下における可視画像の視認性の低下も抑制することができる。 Further, the latent image ink layer and the visible ink layer may be laminated on the surface of the solid preparation at least partially overlapping. Thereby, even when the area of the printable area is small, more information can be recorded on the surface of the solid preparation. In the case where the latent image ink layer and the visible ink layer are laminated in a state where at least a part thereof overlaps, the latent image ink layer is preferably laminated on the visible ink layer. This makes it possible to irradiate the entire area of the latent image ink layer with ultraviolet rays when the ultraviolet rays are irradiated. As a result, the latent image can be visualized in a good state. In addition, since the latent image ink layer has light transmittance in the visible light region, it is possible to suppress a reduction in the visibility of the visible image under visible light irradiation.
 (潜像用水性インク組成物及び潜像用水性インク)
 本実施の形態2に係る潜像インク層の形成に用いる潜像用水性インク組成物について、実施の形態1で用いた潜像用水性インク組成物を用いることができる。従って、その詳細な説明は省略する。
(Latent image water-based ink composition and latent image water-based ink)
As the latent image aqueous ink composition used for forming the latent image ink layer according to the second embodiment, the latent image aqueous ink composition used in the first embodiment can be used. Therefore, the detailed description is abbreviate | omitted.
 (可視画像用水性インク組成物及び可視画像用水性インク)
 前記可視インク層の形成に用いる可視画像用水性インク組成物については特に限定されず、少なくとも1種の染料又は顔料を含み、主溶媒を水とする従来公知の水性インク組成物を用いることができる。また、前記可視画像用水性インク組成物は、薬事法で定める医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合した材料を用いることにより、可食性を有するものにすることができ、かつ、インクジェット方式での画像等の記録に好適に用いることができる。
(Water-based ink composition for visible image and water-based ink for visible image)
The visible ink aqueous ink composition used for forming the visible ink layer is not particularly limited, and a conventionally known aqueous ink composition containing at least one dye or pigment and having a main solvent as water can be used. . Further, the water-based ink composition for visible images can be made edible by using a material that complies with the standards of pharmaceutical additives, Japanese pharmacopoeia, or food additives official regulations specified by the Pharmaceutical Affairs Law. In addition, it can be suitably used for recording an image or the like by an inkjet method.
 前記可視画像用水性インク組成物は、可視光照射下において視認可能なものであることが好ましい。これにより、当該可視画像用水性インク組成物を含む可視画像用水性インクを用いて可視インク層を形成した場合には、目視等による識別を可能にする。 The water-based ink composition for visible image is preferably visible under irradiation with visible light. Thereby, when the visible ink layer is formed using the visible image water-based ink containing the visible image water-based ink composition, identification by visual observation or the like is enabled.
 また、前記可視画像用水性インクは、前記可視画像用水性インク組成物を少なくとも含む。特に、薬事法等で定められている医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合した可視画像用水性インク組成物を用いた場合には、可視画像用水性インクは可食性を有しているので、医薬品又はサプリメント等の錠剤やカプセル剤からなる固体性剤の表面に直接印刷することが可能である。また、素錠及びOD錠など表面の平滑性が悪い錠剤に対しても、インクジェット方式による非接触印刷を可能にする。 The visible image water-based ink contains at least the visible image water-based ink composition. In particular, when a water-based ink composition for visible images that conforms to the standards of pharmaceutical additives, Japanese pharmacopoeia, or food additives official regulations stipulated by the Pharmaceutical Affairs Law, water-based inks for visible images are edible. Therefore, it is possible to print directly on the surface of a solid agent comprising tablets or capsules such as pharmaceuticals or supplements. In addition, non-contact printing by an ink jet method is possible even for tablets with poor surface smoothness such as uncoated tablets and OD tablets.
 (固体製剤の印刷方法)
 本実施の形態2に係る固体製剤の印刷方法は、固体製剤の表面上に可視画像を印刷する可視画像印刷工程と、固体製剤の表面上に潜像を印刷する潜像印刷工程とを少なくとも含む。
(Printing method of solid preparation)
The method for printing a solid preparation according to Embodiment 2 includes at least a visible image printing process for printing a visible image on the surface of the solid preparation, and a latent image printing process for printing a latent image on the surface of the solid preparation. .
 前記可視画像印刷工程は、固体製剤の表面に、前記可視画像用水性インクを用いて可視インク層を印刷することにより、可視画像を形成する工程である。可視インク層を形成する方法としては特に限定されないが、インクジェット方式による印刷が好ましい。インクジェット方式による可視インク層の印刷は、より具体的には、微細なノズルより、可視画像用水性インクを液滴として吐出し、その液滴を固体製剤上に付着させることにより行う。可視画像用水性インクの吐出方法として特に限定されず、例えば、連続噴射型(荷電制御型、スプレー型等)、オンデマンド型(ピエゾ方式、サーマル方式、静電吸引方式等)等の公知の方法を採用することができる。インク滴の吐出量、印刷速度等の印刷条件は特に限定されず、適宜必要に応じて設定することができる。 The visible image printing step is a step of forming a visible image on the surface of the solid preparation by printing a visible ink layer using the visible image water-based ink. A method for forming the visible ink layer is not particularly limited, but printing by an inkjet method is preferable. More specifically, the printing of the visible ink layer by the ink jet method is performed by ejecting the visible image water-based ink as droplets from a fine nozzle and attaching the droplets onto the solid preparation. There are no particular limitations on the method for ejecting the water-based ink for visible images. For example, a known method such as a continuous ejection type (charge control type, spray type, etc.), on-demand type (piezo type, thermal type, electrostatic suction type, etc.) Can be adopted. Printing conditions such as ink droplet ejection amount and printing speed are not particularly limited, and can be set as necessary.
 また、前記可視画像印刷工程には、固体製剤の表面に付着した可視画像用水性インクの液滴を乾燥させる乾燥工程を含むことができる。乾燥方法としては特に限定されず、熱風乾燥の他、自然乾燥等を行うことができる。また、乾燥時間や乾燥温度等の乾燥条件についても特に限定されず、前記液滴の吐出量や可視画像用水性インク組成物の種類等に応じて適宜設定することができる。 The visible image printing step may include a drying step of drying the droplets of the visible image water-based ink attached to the surface of the solid preparation. It does not specifically limit as a drying method, In addition to hot air drying, natural drying etc. can be performed. Also, drying conditions such as drying time and drying temperature are not particularly limited, and can be appropriately set according to the discharge amount of the droplets, the type of the aqueous ink composition for visible images, and the like.
 前記潜像印刷工程は、固体製剤の表面に、前記潜像用水性インクを用いて潜像インク層を印刷することにより、潜像を形成する工程である。潜像インク層を形成する方法としては特に限定されないが、前記可視画像印刷工程の場合と同様、インクジェット方式による印刷が好ましい。インクジェット方式による潜像インク層の印刷は、潜像用水性インクを用いる他は、前記可視画像印刷工程の場合と同様である。また、前記潜像印刷工程には、固体製剤の表面に付着した潜像用水性インクの液滴を乾燥させる乾燥工程を含むことができる。乾燥方法や乾燥条件は前記可視画像印刷工程の場合と同様である。 The latent image printing step is a step of forming a latent image by printing a latent image ink layer on the surface of the solid preparation using the latent ink for latent images. The method for forming the latent image ink layer is not particularly limited, but as in the case of the visible image printing step, printing by an ink jet method is preferable. The printing of the latent image ink layer by the inkjet method is the same as that in the visible image printing step except that the latent image water-based ink is used. The latent image printing step may include a drying step of drying the latent image aqueous ink droplets attached to the surface of the solid preparation. The drying method and drying conditions are the same as those in the visible image printing step.
 ここで、可視画像の印刷領域と潜像の印刷領域を、固体製剤の表面上で相互に異ならせる場合、可視画像印刷工程と潜像印刷工程の順序は特に限定されない。例えば、潜像印刷工程を可視画像印刷工程よりも先に行う場合、可視画像の印刷予定領域とは異なる領域に潜像を印刷すればよい。また、可視画像の印刷領域と潜像の印刷領域を、固体製剤の表面上で少なくとも一部重複させる場合、先ず、可視画像印刷工程において可視画像を印刷した後に、潜像印刷工程において潜像を印刷するのが好ましい。これにより、可視画像と潜像が重複している領域では、可視インク層の上に潜像インク層を積層することができ、当該潜像インク層の顕像化の際に、紫外線が潜像インク層の全領域に照射されるようにすることができる。 Here, when the printing area of the visible image and the printing area of the latent image are made different on the surface of the solid preparation, the order of the visible image printing process and the latent image printing process is not particularly limited. For example, when the latent image printing process is performed before the visible image printing process, the latent image may be printed in an area different from the scheduled printing area of the visible image. In addition, in the case where the visible image printing area and the latent image printing area are at least partially overlapped on the surface of the solid preparation, first, after the visible image is printed in the visible image printing process, the latent image is printed in the latent image printing process. It is preferable to print. As a result, in a region where the visible image and the latent image overlap, the latent image ink layer can be laminated on the visible ink layer, and ultraviolet rays are emitted from the latent image when the latent image ink layer is visualized. The entire area of the ink layer can be irradiated.
 尚、本実施の形態に係る固体製剤の印刷方法においては、前記潜像の顕像化工程を含んでもよい。顕像化工程は、潜像印刷工程で印刷された潜像インク層に、少なくとも100nm~400nmの波長域の紫外線を含む光を照射することにより、潜像の可視化を可能にする工程である。紫外線の照射により、潜像インク層中に均一に含まれる蛍光剤が当該紫外線を吸収し、可視光領域(380nm~760nm)の光を発光(蛍光)する。これにより、蛍光剤が存在する潜像インク層全体が蛍光を発して可視化する。 It should be noted that the solid pharmaceutical printing method according to the present embodiment may include the latent image visualization step. The visualization step is a step that enables the latent image to be visualized by irradiating the latent image ink layer printed in the latent image printing step with light containing ultraviolet rays in a wavelength region of at least 100 nm to 400 nm. When irradiated with ultraviolet rays, the fluorescent agent uniformly contained in the latent image ink layer absorbs the ultraviolet rays and emits (fluoresces) light in the visible light region (380 nm to 760 nm). Thereby, the entire latent image ink layer in which the fluorescent agent is present emits fluorescence and is visualized.
 ここで、紫外線照射前の潜像インク層が可視光領域で無色透明である場合には、当該潜像インク層の蛍光により可視化が可能になる。また、蛍光剤として蛍光染料(赤色3号、赤色104号、赤色105号又は赤色106号)や塩基性染料(クロロフィル又はローダミン)を用い、紫外線照射前の潜像インク層が可視光領域で有色透明である場合には、潜像インク層の蛍光により視認性が一層向上する。 Here, when the latent image ink layer before ultraviolet irradiation is colorless and transparent in the visible light region, the latent image ink layer can be visualized by fluorescence. In addition, fluorescent dyes (red No. 3, red No. 104, red No. 105 or red No. 106) and basic dyes (chlorophyll or rhodamine) are used as fluorescent agents, and the latent image ink layer before UV irradiation is colored in the visible light region. When it is transparent, the visibility is further improved by the fluorescence of the latent image ink layer.
 潜像の顕像化に用いる照射光は、波長域が100nm~400nmの範囲の紫外線を少なくとも含むものであれば特に限定されない。従って、顕像化工程は、例えば、室内において可視光領域の光が存在する中で前記波長域の範囲の紫外線を用いて潜像の可視化を行うことも可能である。尚、本実施の形態で用いる蛍光剤の多くは、280nm~380nmの範囲で吸収波長の極大値を有している。そのため、潜像の顕像化に用いる光には、280nm~380nmの範囲内の紫外線を含めるのがより好ましい。これにより、蛍光剤による紫外線吸収を極大化し、当該蛍光剤が発する蛍光の光強度を一層大きくすることができる。 Irradiation light used for visualization of the latent image is not particularly limited as long as it includes at least ultraviolet rays having a wavelength range of 100 nm to 400 nm. Therefore, in the visualization step, for example, it is possible to visualize the latent image using ultraviolet rays in the wavelength range in the presence of light in the visible range in the room. Note that most of the fluorescent agents used in the present embodiment have a maximum absorption wavelength in the range of 280 nm to 380 nm. For this reason, it is more preferable to include ultraviolet rays within a range of 280 nm to 380 nm in the light used for developing the latent image. Thereby, the ultraviolet absorption by the fluorescent agent is maximized, and the light intensity of the fluorescence emitted by the fluorescent agent can be further increased.
 また、照射光に対しては、例えば、フィルター等を用いて、100nm~400nmの範囲の紫外線以外の光を遮断する必要はない。一般的に販売されている紫外線領域を含んだ光を発する発光機は、紫外線領域以外に可視光領域の光も同時に照射する。そのため、フィルター等を用いて、前記波長域の紫外線以外の光を遮断しようとした場合には、当該紫外線も少なからずフィルターに遮断されてしまう結果、潜像インク層に照射される紫外線の積算光量も減少する場合がある。これにより、潜像インク層が発する蛍光の光強度が低下する場合がある。 In addition, it is not necessary to block light other than ultraviolet rays in the range of 100 nm to 400 nm using, for example, a filter with respect to the irradiation light. In general, a light emitting device that emits light including an ultraviolet region emits light in the visible light region in addition to the ultraviolet region. Therefore, if a filter or the like is used to block light other than the ultraviolet light in the wavelength range, the ultraviolet light is blocked by the filter as a result. As a result, the cumulative amount of ultraviolet light irradiated on the latent image ink layer. May also decrease. Thereby, the light intensity of the fluorescence emitted from the latent image ink layer may decrease.
 また、照射光に含まれる紫外線の波長域は、蛍光剤の種類に応じて適宜設定することができる。また、照射光の積算光量(mJ/cm)は、蛍光剤の種類や潜像インク層中の含有量、光分解性の程度等に応じて適宜設定することができる。 Moreover, the wavelength range of the ultraviolet rays contained in the irradiation light can be appropriately set according to the type of the fluorescent agent. Further, the integrated light amount (mJ / cm 2 ) of the irradiation light can be appropriately set according to the type of the fluorescent agent, the content in the latent image ink layer, the degree of photodegradability, and the like.
 尚、潜像の顕像化工程においては、顕像化された潜像を観察する観察工程を含んでもよい。観察方法としては特に限定されず、目視の他、カメラ等の撮像手段を用いてもよい。撮像手段としては特に限定されず、蛍光剤や記録媒体の種類等に応じて適宜選択することができる。 Note that the latent image visualization step may include an observation step of observing the visualized latent image. The observation method is not particularly limited, and imaging means such as a camera may be used in addition to visual observation. The imaging means is not particularly limited, and can be appropriately selected according to the type of fluorescent agent or recording medium.
 以下に、この発明の好適な実施例を例示的に詳しく説明する。但し、下記の実施例に記載されている材料や含有量等は、特に限定的な記載がない限りは、この発明の範囲をそれらのみに限定するものではない。また、可視画像用水性インク組成物及び潜像用水性インク組成物の各材料は何れも薬事法で定める医薬品添加物、日本薬局方又は食品添加物公定書の基準に適合するものである。 Hereinafter, preferred embodiments of the present invention will be described in detail by way of example. However, materials, contents, and the like described in the following examples are not intended to limit the scope of the present invention only to those unless otherwise specified. In addition, each material of the water-based ink composition for visible images and the water-based ink composition for latent images conforms to the standards of pharmaceutical additives, Japanese pharmacopoeia, or official food additives defined by the Pharmaceutical Affairs Law.
 (実施例1-1)
 下記表1に示す通り、蛍光剤として0.01質量%の赤色3号、表面張力調整剤として2質量%のカプリル酸デカグリセリル(商品名:SYグリスターMCA750、阪本薬品工業(株)製)、湿潤剤として30質量%のプロピレングリコール、及び67.99質量%の純水を混合して、本実施例に係る潜像用水性インク組成物を作製した。得られた潜像用水性インク組成物は、紫外線(波長域100nm~400nm)及び可視光(400nm~760nm)を遮光する容器内に保管した。
Example 1-1
As shown in Table 1 below, 0.01% by weight of red No. 3 as a fluorescent agent, 2% by weight of decaglyceryl caprylate (trade name: SY Glister MCA750, manufactured by Sakamoto Yakuhin Kogyo Co., Ltd.) as a surface tension adjuster, As a wetting agent, 30% by mass of propylene glycol and 67.9% by mass of pure water were mixed to prepare a latent image aqueous ink composition according to this example. The obtained aqueous ink composition for latent images was stored in a container that shields from ultraviolet rays (wavelength range: 100 nm to 400 nm) and visible light (400 nm to 760 nm).
 続いて、前記潜像用水性インク組成物からなる潜像用水性インクを用いて、インクジェット記録方法により、素錠の一方の面に印刷を行い、素錠表面に潜像を含む潜像インク層を形成した(印刷工程、下記表2参照)。潜像インク層は可視光領域において光透過性を有するものであった。 Subsequently, the latent image ink layer containing the latent image on the surface of the uncoated tablet is printed on one surface of the uncoated tablet by an inkjet recording method using the latent image aqueous ink composed of the latent image aqueous ink composition. (Printing process, see Table 2 below). The latent image ink layer was light transmissive in the visible light region.
 印刷は、インクジェットプリンタ(KC 600dpiヘッド、中速印字治具)を用いてシングルパス(ワンパス)方式にて行った。また、印刷は気温25℃、相対湿度40%の環境下で行った。その後、ドライヤーにて熱風を直接当て、印刷面を十分に乾燥させた。これにより、本実施例に係るサンプルを作製した。 Printing was performed by a single pass (one pass) method using an inkjet printer (KC 600 dpi head, medium speed printing jig). Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface. Thus, a sample according to this example was produced.
 続いて、素錠の表面に印刷された潜像インク層に、波長域が280nm~350nmの紫外線を含む光を照射し、潜像インク層中に含まれる蛍光剤を蛍光させた(顕像化工程)。結果を下記表2に示す。尚、顕像化工程は暗所で行った。 Subsequently, the latent image ink layer printed on the surface of the uncoated tablet was irradiated with light containing ultraviolet rays having a wavelength range of 280 nm to 350 nm to cause the fluorescent agent contained in the latent image ink layer to fluoresce (visualization). Process). The results are shown in Table 2 below. The visualization process was performed in a dark place.
 (実施例1-2)
 本実施例においては、蛍光剤として赤色104号を用いた他は、実施例1-1と同様にして潜像用水性インク組成物の作製を行い、かつ、当該潜像用水性インク組成物からなる潜像用水性インクを用いて素錠への印刷を行った。結果を下記表2に示す。
Example 1-2
In this example, a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red 104 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
 (実施例1-3)
 本実施例においては、蛍光剤として赤色105号を用いた他は、実施例1-1と同様にして潜像用水性インク組成物の作製を行い、かつ、当該潜像用水性インク組成物からなる潜像用水性インクを用いて素錠への印刷を行った。結果を下記表2に示す。
(Example 1-3)
In this example, a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red No. 105 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
 (実施例1-4)
 本実施例においては、蛍光剤として赤色106号を用いた他は、実施例1-1と同様にして潜像用水性インク組成物の作製を行い、かつ、当該潜像用水性インク組成物からなる潜像用水性インクを用いて素錠への印刷を行った。結果を下記表2に示す。
(Example 1-4)
In this example, a latent image aqueous ink composition was prepared in the same manner as in Example 1-1 except that Red 106 was used as the fluorescent agent, and the latent image aqueous ink composition was used. Printing on uncoated tablets was performed using the latent image aqueous ink. The results are shown in Table 2 below.
 (実施例1-5)
 本実施例においては、蛍光剤として0.1質量%のトリプトファンを用い、純水の含有量を67.9質量%に変更した他は、実施例1-1と同様にして潜像用水性インク組成物の作製を行い、かつ、当該潜像用水性インク組成物からなる潜像用水性インクを用いて素錠への印刷を行った。結果を下記表2に示す。
(Example 1-5)
In this example, aqueous latent ink for latent images was used in the same manner as in Example 1-1 except that 0.1% by mass of tryptophan was used as the fluorescent agent and the pure water content was changed to 67.9% by mass. The composition was prepared, and printing on uncoated tablets was performed using the latent image aqueous ink composed of the latent image aqueous ink composition. The results are shown in Table 2 below.
 (実施例1-6)
 本実施例においては、蛍光剤として0.1質量%のキニーネを用い、純水の含有量を67.9質量%に変更した他は、実施例1-1と同様にして潜像用水性インク組成物の作製を行い、かつ、当該潜像用水性インク組成物からなる潜像用水性インクを用いて素錠への印刷を行った。結果を下記表2に示す。
(Example 1-6)
In this example, a latent image aqueous ink was used in the same manner as in Example 1-1 except that 0.1% by mass of quinine was used as the fluorescent agent and the pure water content was changed to 67.9% by mass. The composition was prepared, and printing on uncoated tablets was performed using the latent image aqueous ink composed of the latent image aqueous ink composition. The results are shown in Table 2 below.
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002
 (結果1)
 前記表2に示す通り、各実施例1-1~1-6においては、印刷工程直後の印刷画像を視認することができず、又は視認が困難となっており、何れも良好な潜像を印刷することができた。また、印刷面に波長域が280nm~350nmの紫外線を含む光を照射して潜像を顕像化させた後は、印刷画像の目視による可視化を良好に行うことができた。
(Result 1)
As shown in Table 2, in each of Examples 1-1 to 1-6, the printed image immediately after the printing process cannot be visually confirmed or is difficult to visually confirm, and all of them show a good latent image. I was able to print. In addition, after the latent image was visualized by irradiating the printed surface with light containing ultraviolet rays having a wavelength range of 280 nm to 350 nm, the printed image could be visualized well.
 (実施例2-1)
 <可視画像用水性インク組成物の調製>
 本実施例の水性インク組成物においては、染料として4質量%の可食染料(赤色102号3質量%、黄色4号1質量%、緑3号1質量%)(ダイワ化成(株)製)、表面張力調整剤として2質量%のカプリル酸デカグリセリル(商品名:SYグリスターMCA-750、阪本薬品工業(株)製)、湿潤剤として30質量%のプロピレングリコール、及び64質量%の純水を混合して、黒色の可視画像用水性インク組成物を作製した。
Example 2-1
<Preparation of aqueous ink composition for visible image>
In the aqueous ink composition of this example, 4% by weight of edible dye (3% by weight of red No. 102, 1% by weight of No. 4 of yellow, 1% by weight of green No. 3) as a dye (manufactured by Daiwa Kasei Co., Ltd.) 2% by weight decaglyceryl caprylate (trade name: SY Glyster MCA-750, manufactured by Sakamoto Yakuhin Kogyo Co., Ltd.) as a surface tension adjusting agent, 30% by weight propylene glycol and 64% by weight pure water as a wetting agent Were mixed to prepare a black water-based ink composition for visible images.
 <潜像用水性インク組成物の調製>
 下記表3に示す通り、蛍光剤として0.1質量%のリン酸リボフラビンナトリウム、表面張力調整剤として2質量%のカプリル酸デカグリセリル(商品名:SYグリスターMCA-750、阪本薬品工業(株)製)、湿潤剤として30質量%のプロピレングリコール、及び67.9質量%の純水を混合して、黄色ないし橙黄色の潜像用水性インク組成物を作製した。得られた潜像用水性インク組成物は、紫外線(波長域100nm~400nm)及び可視光(400nm~760nm)を遮光する容器内に保管した。
<Preparation of aqueous ink composition for latent image>
As shown in Table 3 below, 0.1% by mass of riboflavin sodium phosphate as a fluorescent agent, and 2% by mass of decaglyceryl caprylate as a surface tension adjuster (trade name: SY Glister MCA-750, Sakamoto Pharmaceutical Co., Ltd.) And 30 wt% propylene glycol as a wetting agent and 67.9 wt% pure water were mixed to prepare a yellow to orange yellow aqueous ink composition for latent images. The obtained aqueous ink composition for latent images was stored in a container that shields from ultraviolet rays (wavelength range: 100 nm to 400 nm) and visible light (400 nm to 760 nm).
 <可視画像の印刷>
 次に、前記可視画像用水性インク組成物からなる可視画像用水性インクを用いて、インクジェット方式により、糖衣錠(糖衣層がショ糖)の一方の面に印刷を行い、糖衣錠表面に可視インク層からなる可視画像を形成した(可視画像印刷工程、下記表4参照)。可視インク層は可視光照射下において視認可能なものであった。
<Printing visible images>
Next, printing is performed on one surface of a sugar-coated tablet (sugar-coated layer is sucrose) by an inkjet method using the visible-image aqueous ink composed of the visible-image aqueous ink composition, and the sugar-coated tablet surface is coated with a visible ink layer. A visible image was formed (visible image printing step, see Table 4 below). The visible ink layer was visible under irradiation with visible light.
 印刷は、インクジェットプリンタ(KC 600dpiヘッド、中速印字治具)を用いてシングルパス(ワンパス)方式にて行った。また、印刷は気温25℃、相対湿度40%の環境下で行った。その後、ドライヤーにて熱風を直接当て、印刷面を十分に乾燥させた。 Printing was performed by a single pass (one pass) method using an inkjet printer (KC 600 dpi head, medium speed printing jig). Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface.
 <潜像の印刷>
 続いて、前記潜像用水性インク組成物からなる潜像用水性インクを用いて、インクジェット方式により、前記糖衣錠における前記可視画像が印刷された面に印刷を行い、糖衣錠表面に潜像を含む潜像インク層を形成した(潜像印刷工程、下記表4参照)。潜像の印刷領域は可視画像の印刷領域とは相互に異なる領域とした。また、潜像インク層は可視光領域において光透過性を有するものであった。
<Latent image printing>
Subsequently, printing is performed on the surface of the sugar-coated tablet on which the visible image is printed by using the latent-image aqueous ink composed of the latent-image aqueous ink composition, and the latent image containing the latent image on the sugar-coated tablet surface is printed. An image ink layer was formed (latent image printing step, see Table 4 below). The latent image print area was different from the visible image print area. Further, the latent image ink layer was light transmissive in the visible light region.
 印刷は、可視画像印刷工程の場合と同様、前記インクジェットプリンタを用いてシングルパス(ワンパス)方式にて行った。また、印刷は気温25℃、相対湿度40%の環境下で行った。その後、ドライヤーにて熱風を直接当て、印刷面を十分に乾燥させた。これにより、本実施例に係る固体製剤の印刷物を作製した。 Printing was performed by a single pass method using the inkjet printer as in the case of the visible image printing process. Printing was performed in an environment with an air temperature of 25 ° C. and a relative humidity of 40%. Thereafter, hot air was directly applied with a dryer to sufficiently dry the printed surface. Thereby, a printed matter of the solid preparation according to this example was produced.
 <潜像の顕像化>
 続いて、糖衣錠の表面に印刷された可視インク層及び潜像インク層に、波長が360nmの紫外線を照射し、潜像インク層中に含まれる蛍光剤を蛍光させた(顕像化工程)。結果を下記表4に示す。尚、顕像化工程は暗所で行った。
<Visualization of latent image>
Subsequently, the visible ink layer and the latent image ink layer printed on the surface of the sugar-coated tablet were irradiated with ultraviolet light having a wavelength of 360 nm to cause the fluorescent agent contained in the latent image ink layer to fluoresce (visualization step). The results are shown in Table 4 below. The visualization process was performed in a dark place.
 (実施例2-2)
 本実施例においては、潜像用水性インク組成物として下記表3に示す組成のものを用いた。また、潜像の印刷は、当該潜像の印刷領域が可視画像の印刷領域と重複するように行った。さらに、固体製剤として糖衣錠に代えてFC錠を用いた。これら以外は、前記実施例2-1と同様にして本実施例に係る固体製剤の印刷物を作製した。さらに、実施例2-1と同様の方法にて糖衣錠の表面に印刷された潜像の顕像化を行った。結果を下記表4に示す。
(Example 2-2)
In this example, the water-based ink composition for latent images having the composition shown in Table 3 below was used. The latent image was printed such that the latent image print area overlapped with the visible image print area. Furthermore, FC tablets were used instead of sugar-coated tablets as solid preparations. A printed material of the solid preparation according to this example was prepared in the same manner as in Example 2-1, except for these. Further, the latent image printed on the surface of the sugar-coated tablet was visualized by the same method as in Example 2-1. The results are shown in Table 4 below.
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004
 (結果2)
 前記表4に示す通り、各実施例2-1及び2-2においては、可視光照射下において糖衣錠の表面に良好な可視画像を視認することができた。その一方、何れの固体製剤においても、可視光照射下では潜像を識別することはできなかった。さらに、印刷面に波長360nmの紫外線を照射すると、潜像インク層から可視光領域の蛍光が発生し、潜像を顕像化(可視化)させることができた。これにより、前記紫外線照射下では、潜像を良好に視認することができた。
(Result 2)
As shown in Table 4, in each of Examples 2-1 and 2-2, a good visible image could be visually recognized on the surface of the sugar-coated tablet under visible light irradiation. On the other hand, in any solid preparation, the latent image could not be identified under visible light irradiation. Furthermore, when ultraviolet rays having a wavelength of 360 nm were irradiated on the printing surface, fluorescence in the visible light region was generated from the latent image ink layer, and the latent image could be visualized (visualized). As a result, the latent image could be viewed well under the ultraviolet irradiation.

Claims (17)

  1.  可視光領域で光透過性を有し、潜像を印刷するための潜像用水性インク組成物であって、
     波長域が100nm~400nmの範囲の紫外線照射により可視光領域で蛍光を発する蛍光剤を少なくとも含み、
     前記蛍光剤が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種であり、
     前記蛍光剤の含有量が潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内である潜像用水性インク組成物。
    A water-based ink composition for a latent image, having light transmittance in a visible light region, for printing a latent image,
    Including at least a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm,
    The fluorescent agent is riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red No. 3, red No. 104, Red 105, Red 106, fumarate, at least one selected from the group consisting of chlorophyll and rhodamine,
    The aqueous latent ink composition for latent images, wherein the content of the fluorescent agent is in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images.
  2.  前記潜像用水性インク組成物が、固体製剤に対するインクジェット方式での潜像の印刷に用いられるものであり、
     前記蛍光剤が可食性を有する請求項1に記載の潜像用水性インク組成物。
    The latent ink composition for latent image is used for printing a latent image in an ink jet system for a solid preparation,
    The aqueous ink composition for latent images according to claim 1, wherein the fluorescent agent is edible.
  3.  記録媒体の表面の少なくとも一部に潜像が設けられた印刷物であって、
     前記潜像は、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層からなり、
     前記潜像インク層が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種の蛍光剤を含む印刷物。
    A printed matter in which a latent image is provided on at least a part of the surface of a recording medium,
    The latent image is composed of a latent image ink layer that has optical transparency to visible light and emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
    The latent image ink layer comprises riboflavin, riboflavin butyrate, sodium riboflavin phosphate, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red No. 3, red 104 No., Red No. 105, Red No. 106, printed matter containing at least one fluorescent agent selected from the group consisting of fumarate, chlorophyll and rhodamine.
  4.  前記潜像インク層が潜像用水性インクの乾燥被膜からなり、
     前記潜像用水性インクが、前記蛍光剤を含む潜像用水性インク組成物を含むものであり、
     前記蛍光剤の含有量が前記潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内である請求項3に記載の印刷物。
    The latent image ink layer is composed of a dry film of a latent image aqueous ink,
    The latent image water-based ink contains a latent image water-based ink composition containing the fluorescent agent,
    The printed matter according to claim 3, wherein the content of the fluorescent agent is in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images.
  5.  前記記録媒体が固体製剤である請求項3又は4に記載の印刷物。 The printed matter according to claim 3 or 4, wherein the recording medium is a solid preparation.
  6.  前記蛍光剤が可食性を有する請求項3~5の何れか1項に記載の印刷物。 The printed matter according to any one of claims 3 to 5, wherein the fluorescent agent is edible.
  7.  表面の少なくとも一部に、潜像と可視画像が設けられた固体製剤の印刷物であって、
     前記潜像は、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層からなり、
     前記可視画像は、可視光照射下で視認可能な可視インク層からなる固体製剤の印刷物。
    A printed product of a solid preparation in which a latent image and a visible image are provided on at least a part of the surface,
    The latent image is composed of a latent image ink layer that has optical transparency to visible light and emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
    The visible image is a printed product of a solid preparation composed of a visible ink layer that is visible under visible light irradiation.
  8.  前記潜像インク層が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種の蛍光剤を含む請求項7に記載の固体製剤の印刷物。 The latent image ink layer comprises riboflavin, riboflavin butyrate, sodium riboflavin phosphate, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red No. 3, red 104 The printed matter of the solid formulation of Claim 7 containing at least 1 sort (s) of fluorescent agent chosen from the group which consists of No., red 105, red 106, fumarate, chlorophyll, and rhodamine.
  9.  前記潜像インク層が潜像用水性インクの乾燥被膜からなり、
     前記潜像用水性インクが、前記蛍光剤を含む潜像用水性インク組成物を含むものであり、
     前記蛍光剤の含有量が前記水性コーティング組成物の全質量に対し0.001質量%~10質量%の範囲内である請求項8に記載の固体製剤の印刷物。
    The latent image ink layer is composed of a dry film of a latent image aqueous ink,
    The latent image water-based ink contains a latent image water-based ink composition containing the fluorescent agent,
    The printed material of the solid preparation according to claim 8, wherein the content of the fluorescent agent is in the range of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous coating composition.
  10.  前記可視インク層と潜像インク層は、前記表面上の異なる領域にそれぞれ設けられ、又は前記表面上に少なくとも一部重複した状態で順次積層されている請求項7~9の何れか1項に記載の固体製剤の印刷物。 10. The visible ink layer and the latent image ink layer according to any one of claims 7 to 9, wherein the visible ink layer and the latent image ink layer are respectively provided in different regions on the surface, or are sequentially stacked on the surface so as to at least partially overlap each other. Printed product of the described solid preparation.
  11.  前記蛍光剤が可食性を有する請求項7~10の何れか1項に記載の固体製剤の印刷物。 The printed matter of the solid preparation according to any one of claims 7 to 10, wherein the fluorescent agent has edible properties.
  12.  固体製剤の表面の少なくとも一部に、潜像及び可視画像を印刷する固体製剤の印刷方法であって、
     前記固体製剤の表面上に、可視光照射下で視認可能な可視インク層を印刷して、前記可視画像を形成する可視画像印刷工程と、
     前記可視画像の印刷領域とは異なる領域、当該可視画像の印刷予定領域とは異なる領域、又は当該可視画像の印刷領域と少なくとも一部重複する領域に、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層を印刷して、前記潜像を形成する潜像印刷工程とを含む固体製剤の印刷方法。
    A method for printing a solid preparation, wherein a latent image and a visible image are printed on at least a part of the surface of the solid preparation,
    On the surface of the solid preparation, a visible ink layer that is visible under irradiation with visible light is printed to form the visible image, and a visible image printing step,
    An area that is different from the visible image print area, an area that is different from the visible image print area, or an area that at least partially overlaps the visible image print area; And a latent image printing step of forming a latent image by printing a latent image ink layer that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm.
  13.  前記潜像印刷工程は、潜像用水性インク組成物を含む潜像用水性インクを用いて、インクジェット方式により前記潜像インク層の印刷を行う工程であり、
     前記潜像用水性インク組成物は、波長域が100nm~400nmの範囲の紫外線の照射により可視光領域の蛍光を発する蛍光剤を含み、かつ、可視光領域で光透過性を有するものである請求項12に記載の固体製剤の印刷方法。
    The latent image printing step is a step of printing the latent image ink layer by an inkjet method using a latent image aqueous ink containing a latent image aqueous ink composition,
    The latent ink composition for latent images contains a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm, and has light transmittance in the visible light region. Item 13. A method for printing a solid preparation according to Item 12.
  14.  前記蛍光剤として、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種を用いる請求項13に記載の固体製剤の印刷方法。 Examples of the fluorescent agent include riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red No. 3, red No. 104, The method for printing a solid preparation according to claim 13, wherein at least one selected from the group consisting of Red No. 105, Red No. 106, fumarate, chlorophyll and rhodamine is used.
  15.  前記蛍光剤の含有量が前記潜像用水性インク組成物の全質量に対し0.001質量%~10質量%である請求項13又は14に記載の固体製剤の印刷方法。 The method for printing a solid preparation according to claim 13 or 14, wherein the content of the fluorescent agent is 0.001% by mass to 10% by mass with respect to the total mass of the aqueous ink composition for latent images.
  16.  潜像用水性インク組成物を含む潜像用水性インクを用いて、記録媒体上に潜像を印刷する潜像用水性インクの使用方法であって、
     前記記録媒体の表面上に、可視光に対し光透過性を有し、かつ、波長域が100nm~400nmの範囲の紫外線照射により可視光領域の蛍光を発する潜像インク層を印刷して、前記潜像を形成する潜像印刷工程と、
     前記潜像インク層に、少なくとも100nm~400nmの波長域の紫外線を含む光を照射することにより、当該潜像インク層で可視光領域の蛍光を発生させ、前記潜像を顕像化させる顕像化工程とを含み、
     前記潜像用水性インク組成物として、
     波長域が100nm~400nmの範囲の紫外線照射により可視光領域で蛍光を発する蛍光剤を少なくとも含み、
     前記蛍光剤が、リボフラビン、リボフラビン酪酸エステル、リボフラビンリン酸エステルナトリウム、桂皮酸誘導体、L-トリプトファン、チロシン、フェニルアラニン、キニーネ、キニーネ塩酸塩2水和物、硫酸キニーネ、赤色3号、赤色104号、赤色105号、赤色106号、フマル酸塩、クロロフィル及びローダミンからなる群より選ばれる少なくとも1種であり、
     前記蛍光剤の含有量が潜像用水性インク組成物の全質量に対し0.001質量%~10質量%の範囲内のものを用いる潜像用水性インクの使用方法。
    A method for using a latent image water-based ink for printing a latent image on a recording medium using a latent image water-based ink containing a latent image-based water-based ink composition, comprising:
    On the surface of the recording medium, a latent image ink layer having optical transparency to visible light and emitting fluorescence in the visible light region by irradiation with ultraviolet rays having a wavelength range of 100 nm to 400 nm is printed. A latent image printing process for forming a latent image;
    By irradiating the latent image ink layer with light containing ultraviolet rays having a wavelength range of at least 100 nm to 400 nm, the latent image ink layer generates fluorescence in the visible light region and visualizes the latent image. Including
    As the latent ink composition for latent images,
    Including at least a fluorescent agent that emits fluorescence in the visible light region when irradiated with ultraviolet rays having a wavelength range of 100 nm to 400 nm,
    The fluorescent agent is riboflavin, riboflavin butyrate ester, sodium riboflavin phosphate ester, cinnamic acid derivative, L-tryptophan, tyrosine, phenylalanine, quinine, quinine hydrochloride dihydrate, quinine sulfate, red No. 3, red No. 104, Red 105, Red 106, fumarate, at least one selected from the group consisting of chlorophyll and rhodamine,
    A method of using an aqueous latent image ink, wherein the fluorescent agent is used in an amount of 0.001% by mass to 10% by mass with respect to the total mass of the aqueous latent ink composition.
  17.  前記記録媒体として固体製剤を用いる請求項16に記載の潜像用水性インクの使用方法。 The method for using a latent image water-based ink according to claim 16, wherein a solid preparation is used as the recording medium.
PCT/JP2018/014057 2017-04-06 2018-04-02 Latent image aqueous ink composition, usage method and printed object thereof, printed object of solid preparation, and method for printing solid preparation WO2018186324A1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2017-075689 2017-04-06
JP2017075689 2017-04-06
JP2017112878A JP6943636B2 (en) 2017-06-07 2017-06-07 Printed matter of solid product and printing method of solid product
JP2017-112878 2017-06-07
JP2018036818A JP7204084B2 (en) 2017-04-06 2018-03-01 Water-based ink composition for inkjet, method of use and printed matter
JP2018-036818 2018-03-01

Publications (1)

Publication Number Publication Date
WO2018186324A1 true WO2018186324A1 (en) 2018-10-11

Family

ID=63712253

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2018/014057 WO2018186324A1 (en) 2017-04-06 2018-04-02 Latent image aqueous ink composition, usage method and printed object thereof, printed object of solid preparation, and method for printing solid preparation

Country Status (1)

Country Link
WO (1) WO2018186324A1 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849765A (en) * 1981-09-21 1983-03-24 Nippon Telegr & Teleph Corp <Ntt> Invisible ink for ink-jet printer
JPH0381376A (en) * 1989-08-24 1991-04-05 Dainippon Ink & Chem Inc Water-base fluorescent ink for ink jet recording
JP2007510796A (en) * 2003-11-06 2007-04-26 ヒューレット−パッカード デベロップメント カンパニー エル.ピー. System and method for edible optically invisible ink
JP2009241404A (en) * 2008-03-31 2009-10-22 Dainippon Printing Co Ltd Recording medium
JP2011241312A (en) * 2010-05-19 2011-12-01 Toyo Ink Sc Holdings Co Ltd Ink discernible by ultraviolet irradiation
JP2017057344A (en) * 2015-09-18 2017-03-23 株式会社Screenホールディングス Inkjet aqueous ink composition and solid formulation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849765A (en) * 1981-09-21 1983-03-24 Nippon Telegr & Teleph Corp <Ntt> Invisible ink for ink-jet printer
JPH0381376A (en) * 1989-08-24 1991-04-05 Dainippon Ink & Chem Inc Water-base fluorescent ink for ink jet recording
JP2007510796A (en) * 2003-11-06 2007-04-26 ヒューレット−パッカード デベロップメント カンパニー エル.ピー. System and method for edible optically invisible ink
JP2009241404A (en) * 2008-03-31 2009-10-22 Dainippon Printing Co Ltd Recording medium
JP2011241312A (en) * 2010-05-19 2011-12-01 Toyo Ink Sc Holdings Co Ltd Ink discernible by ultraviolet irradiation
JP2017057344A (en) * 2015-09-18 2017-03-23 株式会社Screenホールディングス Inkjet aqueous ink composition and solid formulation

Similar Documents

Publication Publication Date Title
JP7021982B2 (en) Water-based coating composition for inkjet, printing method and printed matter
US7166154B2 (en) System and a method for an edible, optically invisible ink
JP4624224B2 (en) System and method for creating edible optically invisible images
CN110088212B (en) Aqueous ink composition for inkjet, method for suppressing fading of printed image in solid preparation, and solid preparation
JP7084145B2 (en) Inkjet water-based ink compositions and solid formulations
WO2018168733A1 (en) Ink-jet aqueous coating composition, printing method, and printed article
WO2019065512A1 (en) Water-based ink-jet ink composition, method for suppressing fading of printed images on solid formulations, and solid formulation
JP7204084B2 (en) Water-based ink composition for inkjet, method of use and printed matter
JP6943636B2 (en) Printed matter of solid product and printing method of solid product
JP2022087121A (en) Blue inkjet ink and tablet
JP2018188416A (en) Latent image printed matter of solid formulation and imaging method therefor
JP7154956B2 (en) Inkjet overcoat composition and printed matter
JP6637276B2 (en) Aqueous ink composition for inkjet and solid preparation
JP6993278B2 (en) Aqueous ink precursor composition for latent images, a method for producing the same, and an aqueous ink composition for latent images.
WO2018186324A1 (en) Latent image aqueous ink composition, usage method and printed object thereof, printed object of solid preparation, and method for printing solid preparation
TWI682857B (en) Aqueous ink composition for latent image, printed matter, and printed matter of solid preparation
JP7420176B2 (en) Inkjet ink, tablets, printing machines and tablet manufacturing methods
JP2018188417A (en) Latent image printed matter of solid formulation and imaging method therefor
WO2018198704A1 (en) Latent image printed matter of solid formulation and imaging method therefor, and examination method for edible material
TWI664095B (en) Latent image printed matter of solid formulation, imaging method thereof and method for inspecting edible material
JP2019007900A (en) Inspection method of edible article
JP2017165862A (en) Aqueous ink composition for inkjet, manufacturing method therefor and solid formulation
KR102290817B1 (en) Aqueous ink composition for inkjet, method for suppressing discoloration of printed image of solid formulation, and solid formulation
TWI825795B (en) Ink, method for manufacturing printed tablets using the same, and tablet printing device
JP2020073666A (en) Aqueous ink composition for inkjet and solid formulation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18781646

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18781646

Country of ref document: EP

Kind code of ref document: A1